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ABSTRACT
Protein-derived cofactors are redox and catalytic centers that are generally formed
by the posttranslational modifications of one or more amino acids. An important class of
these cofactors are the quinones derived from tyrosine and tryptophan. Amongst redox
proteins, it has been known till now that oxidases either contain a flavin or a
tyrosylquinone cofactor, whereas tryptophylquinone ones are present within the
dehydrogenases. In recent times, oxidases from a marine bacterium, Marinomonas
mediterranea, have been shown to possess the latter. This study involves the
characterization of two such proteins, lysine-ε-oxidase (LodA) and glycine oxidase
(GoxA). They have been reported to contain the same cysteine tryptophylquinone (CTQ)
cofactor. Both require the co-expression of a second protein, LodB and GoxB respectively
to generate matured CTQ containing active protein. Kinetic analysis of the reaction
catalyzed by LodA showed that it followed the usual Michaelis-menten mode of interaction
with its substrates. GoxA on the other hand exhibited allosteric cooperativity for its
substrate glycine. This was attributed to the dimeric conformation of the wildtype GoxA
based on size exclusion chromatographic studies. Mutagenesis study of amino acid
residues based on the crystal structure of LodA and a homology model of GoxA, have
given a detailed idea about their structure-function relationship. Kinetic studies on
mutants of Tyr211 of LodA along with Lys530 present at the substrate channel, showed
effects on both Km for the substrates and kcat for the reaction. As a result these residues
have shown their involvement in forming a gate-like structure to control the to and fro
movement of the substrate and products. Corresponding to this residue, the Phe237 of
iii

GoxA has proved to be important in maintaining the allostericity, by mediating the stable
dimer formation. From the kinetic parameters, Cys448 of LodA was found to be
responsible for substrate specificity and affinity. Whereas, mutants of His466 of GoxA that
correspond to the Cys448 residue, were unable to yield CTQ containing active GoxA. On
the other hand, Asp512 of LodA and Asp547 of GoxA that correspond to each other, have
been implicated for their involvement in CTQ biogenesis. This study therefore highlights
how even though this new pool of enzymes have great degrees of similarity in terms of
the cofactors and conserved active site residues, there are major differences in the
mechanism of the reaction that they catalyze which on a broader sense could influence
the overall physiological importance of the enzyme in the biological system.
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This work is dedicated to my parents, Mr. Prasanta Sehanobish and Mrs. Mridula
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CHAPTER 1: GENERAL INTRODUCTION
Oxidases and dehydrogenases belong to the oxidoreductase group of redox
enzymes. They are involved in catalyzing the transfer of electrons between different
substances in these redox reactions1. The basic difference between an oxidase and a
dehydrogenase lies in the type of the final electron acceptor they use in the reactions
catalyzed by them. Oxidases as per the name, use O2 whereas dehydrogenases use
molecules such as NAD+ 2 or other redox proteins to accept their electrons. Since redox
enzymes are of great importance in various biological pathways such as respiration and
metabolism3, studying different proteins of this category is of utmost importance.
Most of these redox proteins and enzymes have cofactors that act as the redox
active centers. Protein cofactors can be of different types. There are the inorganic ions
such as Zn, Mg, Cu, Fe which are readily found in metalloproteins. The organic cofactors
include the NAD, FAD (Flavin Adenine dinucleotide) and FMN (Flavin mononucleotide).
Most of these cofactors can be easily detected by Uv/Vis spectroscopy. The latter two are
generally found in flavoproteins. For e.g. changes in the absorbance spectrum of FAD
around 450 nm indicates the oxidation state of the Flavin containing proteins 4. The other
class of cofactors include the ones that have been generated by posttranslational
modification of already existing amino acids. In recent years a lot of interesting research
has been done on this and continues to be a growing area for more investigations. Certain
amino acids especially the aromatic ones undergo post translational modification and
further crosslink to adjacent amino acids to generate redox active centers. The earliest
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known form of such cofactors was that of pyrroloquinoline quinone (PQQ) and proteins
containing these cofactors were specifically called quinoproteins 5.

From the data

available it has been observed that the tryptophan derived cofactors are generally present
in dehydrogenases for e.g. MADH containing TTQ. Oxidases that are quinoproteins
generally contain tyrosine derived cofactors, for e.g. amine oxidase containing TPQ 6.
It is known that L-amino acid oxidases are generally flavoproteins containing
Flavin-derived cofactors7. For the first time an oxidase was discovered from a marine
melanogenic bacteria, Marinomonas mediterranea, which showed lysine-ε-oxidase
activity8. The unique property of this enzyme is that it contained a posttranslationally
modified tryptophylquinone cofactor, CTQ, just like a dehydrogenase, but enzymatically
behaved as an oxidase. This protein was named LodA and was encoded by the lodA
gene. The only other reported example of a CTQ containing enzyme was a
dehydrogenase called quinohemoprotein amine dehydrogenase (QHNDH)9. Due to
complexity in its structure QHNDH wasn’t studied completely. LodA was found to catalyze
the oxidative deamination of L-lysine generating hydrogen peroxide that made it
antimicrobial in nature10. Hence this was an interesting protein to study to understand
how even though it contained an intrinsic property of a dehydrogenase (i.e. CTQ), it still
managed to behave as an oxidase.
In this study the mechanism of action has been studied. To understand the
significance and importance of the enzyme, the elucidation of the reaction mechanism
was necessary, as it is the presence of the CTQ that makes the enzyme active. Precursor
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forms of the enzyme without the CTQ were found to be inactive11. From the data obtained
it has been shown that LodA carries out the oxidative deamination by following a pingpong mechanism12 and occurs via the formation of a Schiff base intermediate. Its
reductive half reaction resembles those of all other tryptophylquinone containing
dehydrogenases and tyrosyl quinone containing oxidase. Yet it is different from both of
these categories of redox proteins. To further characterize this and understand the
structure-function relationship, site-directed mutagenesis was done. Cys516 and Trp581
were involved in the CTQ formation. These were mutated to Alanine. None of the variants
produced any active protein and no CTQ was detected in any of those mutants. Various
possible significant residues were mutated like the Cys448, Tyr211 and Lys530 to see
their effects on both structure and function of LodA13. Cys448 was found to be involved
in the determining the substrate specificity and binding especially for lysine. An aromatic
amino acid was required at the 211 position (Tyr211) which along with the Lys530 formed
a hydrophobic pocket as they Hydrogen (H) bonded with each other. This affected the
entry and exit of products and intermediates hence modulating the reaction rate and
affinities for both O2 and L-lysine.
On further genome analysis it was seen that 2 other genes from the same bacteria
were found to encode LodA-like proteins14. This led one to believe that there is a whole
reservoir of such oxidases that contain trytophylquinone cofactors. Amongst the two, one
of them showed glycine oxidase activity14 and was named as GoxA. This was first
discovered in Marinomonas mediterranea and was then recombinantly expressed in
E.coli. It was found to be inactive in the precursor form that was devoid of a mature CTQ
3

11.

In this study we further characterize GoxA and try to elucidate the structure-function

relationship. Since this was similar to LodA, it was thought that probably the mode of
reaction mechanism was the same with the major difference being in the substrate which
is Glycine for Gox. Hence kinetic analysis of the enzyme for the oxidative deamination of
glycine was studied. This enzyme showed allosteric cooperativity for glycine which was
absolutely unique and different from LodA. The dimeric form of the enzyme was thought
to support this mode of reaction. Presence of glycine facilitates the binding of substrate
at the other subunits thus increasing the overall reaction rate since the enzyme shows
positive cooperativity. The fact that it showed an allosteric mechanism could mean that
this has more metabolic function than antimicrobial as in the case of LodA. The crystal
structure of GoxA has not yet been determined. This poses a problem in general to study
any type of enzymes it terms of their structure-function. So its homology model was
created with LodA as the reference and site directed mutagenesis was done. Residue
His466 was analogous to Cys448 and Phe237 was analogous to Tyr211. H466 was found
to be directly or indirectly involved in the CTQ biosynthesis because mutating this residue
generated inactive precursor protein. On the other hand mutation of F237 resulted in the
loss of cooperativity for glycine by forming weaker dimer with the subunits. This study
therefore shows how apparently similar enzymes have different mechanism of catalyzing
reactions and how just from this mechanism one can predict the overall physiological
function of the enzyme.

4

CHAPTER 2: LITERATURE REVIEW
Cofactors of a protein
Cofactors are known to be molecules associated with proteins that make a protein
active. In the absence of these cofactors proteins are still in their precursor form and are
inactive in nature. A lot of the functional groups present in a protein may account for some
of the catalysis, nucleophilic and electrophilic reactions but cannot account for the
catalysis of many other enzymatic reactions. It is here that the presence of cofactors
becomes very important. An inactive enzyme without the cofactor has been termed as
the apoenzyme and the entire active protein has been named as the holoenzyme

15.

The

cofactors are not only involved in accelerating the reaction rate of the catalyzed reaction
but later studies also showed the involvement of cofactors in protein folding and protein
stability 16. According to these studies, the cofactor was found to be involved in stabilizing
the native protein. This was possible by the interaction of the cofactor with unfolded
polypeptide. Often this interaction prior to the protein folding step could speed up the
overall folding process. Thus along with enhancing the reaction rates these cofactors
adds diversity in the functions of the enzymes at times making them redox active centers
or allowing the coordination with different substrates15.
There are mainly 4 different types of cofactors. There are the metalloproteins which
contain metal ions as their primary cofactors. A large number of these metal ions have
been found associated with protein activity. Some of them include Copper (Cu), Iron (Fe),
Zinc (Zn), Magnesium (Mg), Cobalt (Co), Molybdenum (Mo)17. The second category of
5

cofactors are the organic ones which since they are directly involved in enzymatic
reactions hence could also be termed as coenzymes. The most common example for
coenzymes are the FAD, NAD+ 2. Another category of cofactors are the organometallic
ones. These have metal ions tightly associated to the organic moieties in the protein and
cannot be dissociated from it easily. The most common example for this is heme that
contains Fe associated to a porphyrin ring. The final category of cofactors are the ones
that have been generated by the posttranslational modification of amino acid residues in
proteins. Some of these are self-generated and some require the presence of other
proteins to catalyze the biosynthesis of the cofactors6. Examples of some of these
cofactors include tryptophylquinone cofactors that have been formed from modifications
in tryptophan residues18. In general many of these cofactors have spectroscopic UV/Vis
and fluorescence properties and protein cofactor interactions may influence these
properties. If these cofactors are present at the active site of the enzyme then its
interaction with the protein is thought to influence the enzyme kinetics and thus the steady
state analysis is a good tool to study any such interactions. If the protein is a redox protein
then the presence of these cofactors often influence the redox potentials and thus doing
redox titrations can give one a good understanding of its affects 19. Midpoint redox
potential values maybe affected in the presences and absence of these cofactors20, 21.
Metal ions have also been implicated in many infectious diseases22. Hence studying
protein-cofactor interactions is a good technique to figure out their importance.

6

Inorganic metal ions
Metalloproteins as the name suggests are proteins which have inorganic ions as
cofactors. These metal ions are important in catalytically and redox active proteins since
they often provide different oxidation states that help in redox reactions and electron
transfer reactions. Often these metals are coordinated to different amino acid side chains
and these are pretty strong interactions such that they don’t generally leach out upon
purification of these proteins. A large number of metal ions have been found to be present
in the protein. These include Fe, Cu, Zn, Mg, Ni, Mn and Zn. Surrounding amino acid
residues provide ligands for these metals which in turn tend to influence the stability and
the reactivity of the metals. Examples of 2 intriguing redox active metals iron and copper,
containing proteins are stated below.
Iron (Fe) containing proteins
Iron is the more abundantly available transition metal ion which when present
as a cofactor has physiological importance. Its ability to readily undergo a transition
between Fe (II) and Fe (III) redox state makes it indispensable15. More than one oxidation
state of iron allows it to be readily involved in the reactions involving the transfer of
electrons. Iron cofactors can be directly bound to the amino acid side chains or in cases
such as the heme it might be coordinated to porphyrin rings and thus will be part of
organometallic complexes. A common example of Fe being bound to amino acids is in
the metalloprotein intradiol catechol dioxygenase23. This belongs to oxidoreductases and
they incorporate dioxygen into the substrates thus carrying out the oxidative cleavage of
7

catechols. Iron also has been found to be present as a cofactor along with Copper in an
oxidase, cytochrome c oxidase which plays a major role in oxidative phosphorylation.
Another category of Iron containing proteins are Iron-Sulphur proteins. They contain FeS clusters with more than one Fe and sulphide linkages24. These clusters have been
found in various different metalloproteins such as the Nitrogenase, Ferredoxins, NADH
dehydrogenase and are more commonly known for their involvement in electron transfer
in redox reaction with some being integral part of the mitochondrial respiratory chain.
Copper (Cu) containing proteins
A reason for the abundant presence of copper in proteins is its ability to exist both
in the oxidized and reduced state. Based on its oxidation state it can either have affinity
for thiols or thioether groups or in some cases have can coordinate with O 2 or imidazole
nitrogen groups25. Based on the surrounding ligands and the coordination number the
copper containing proteins are able to exhibit different chemical and spectroscopic
properties26. Type I copper containing proteins have been termed as cupredoxins in which
the copper is coordinated by four residues. This is the most studied type of copper
containing proteins. Examples of this are plastocyanin and azurin. Plastocyanins are
involved in electron transfer during photosynthesis. Azurin too is involved in electron
transfer in bacteria. These proteins are blue in appearance and have a strong absorption
around 600nm thus depicting the color26. Galactose oxidase which is an oxidoreductase
involved in the reduction of galactose contains a Type II copper center27.
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Organometallic cofactors
Sometimes the metal maybe tightly associated or bound to organic moieties and
do not dissociate readily. They have been known to be involved in redox and catalytic
reactions. Such cofactors would be referred to as the organometallic ones 15. Common
examples are heme with iron attached to the porphyrin ring and cobalamin which has
cobalt attached to the corrin ring. Heme containing proteins are discussed below.
Heme
Heme is one of the more important and abundantly available organometallic cofactors,
observed in biological systems. It consists of an iron atom present in the center of the
porphyrin ring. Based on the substitutions and coordination, the heme group can be
classified into different types. The most common one is the heme b. it is coordinated to
different ligand amino acids based on the type of protein in which it is present as a
prosthetic group. For example it is coordinated to Histidine in hemoglobin28 and
myoglobin29. Hemoglobin as is known is the iron containing oxygen transporter present
in the red blood cells of vertebrates whereas myoglobin does the same function but is
present in the muscle tissues of vertebrates and most mammals. Hence the heme present
in these two proteins aid in their overall function as the oxygen-binding proteins. Two
other heme b containing proteins are the nitric oxide synthase30 and the cytochrome
P45031. These have cysteine as their ligand. The other forms are the heme a and heme
c. Cytochrome c oxidase contains heme a whereas the other c-type cytochromes such
as bacterial diheme cytochrome c peroxidase contains heme c.

9

Organic cofactors
Coenzymes are organic molecules that act as cofactors and are required for the
activity of the protein. Many of these coenzymes have been derived from vitamins B1, B2
and B6. These organic molecules can either be covalently bound to the protein or be
loosely bound to it thus being dissociable. Nicotinamide adenine dinucleotide (NAD +) is a
dissociable cofactor whereas cofactors like Flavin adenine mononucleotide/dinucleotide
(FMN, FAD) and pyridoxal phosphate (PLP) are strongly associated and cannot be
separated until the protein gets denatured. These cofactors especially the NAD + and the
FAD and FMN are involved in electron transfer hence are often found in oxidases and
dehydrogenases. These cofactors generally have characteristic binding domains in
proteins.
Nicotinamide adenine dinucleotide (NAD)
It is an important coenzyme used in biological systems. It has been implicated in
processes such as glycolysis and citric acid cycle. Due to its ability to be involved in redox
reactions, it can exist as an oxidized form (NAD+) or as a reduced form (NADH). They
have characteristic absorption maxima at 250 nm and 340 nm respectively. Many known
dehydrogenases use NAD as their cofactor. Glutamate dehydrogenase for example uses
NAD+ as its cofactor to catalyze the production of ammonia and α-ketoglutarate, based
on the biological system and the binding affinity for the substrates. For example it has
been found to be central in amino acid catabolism in plants32 and in mammals33 it has
been found to be important in ammonia metabolism all of which requires the ability of the
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protein to use NAD as its cofactor rather coenzyme. Another common example of an
NAD+ using enzyme is the alcohol dehydrogenase which has a definite binding site for
the cofactor and catalyzes the oxidation of ethanol.

Flavin adenine dinucleotide (FAD), Flavin mononucleotide (FMN)
These cofactors have been derived from riboflavin. FADs, like the NAD cofactors are also
involved in redox reactions and hence can exist in the oxidized and the reduced form.
The oxidized form of FAD shows an absorption maxima at around 450nm. Free Flavin
also exhibits fluorescence which gets quenched as and when it binds to the proteins4. For
most of these proteins denaturation needs to be done in order to release the tightly bound
cofactors. Various proteins have been known to contain these cofactors. Nitric oxide
synthase contains both the FAD and FMN in a 2:1 ratio 34. The only other mammalian
protein known to contain the same is the NADPH-cytochrome P-450 oxidoreductase in
which the 2 are present in equimolar amounts35. Another protein called thioredoxin
reductase, thought to be a key component of the thioredoxin system supplying hydrogen
for reduction of ribonucleotides also contained 2 molecules of FAD per molecule of the
protein36.
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Cofactors generated by posttranslational modification
Posttranslational modification is a process which involves changes in proteins
after the process of translation has been complete. It can involve addition or removal of
functional groups. Some of them include phosphorylation involving the addition of a
phosphate group, glycosylation involving the addition of a carbohydrate molecules and
methylation involving the addition of methyl groups. Posttranslational modification occur
on amino acid residues present at the surface or at the C or N terminal of the protein.
Sometimes the posttranslational modifications involve cleaving off peptides to generate
active protein. Since the modifications occur at the surface, the amino acids susceptible
to it are easily accessible. These posttranslational modifications tend to affect different
important biological processes such as cell signaling.
Within a protein or a peptide, the amino acids that are available tend to have
limited chemical functionality in proteins. In most cases they either use already present
cofactors or exogenous ones to help in catalysis. But some of these redox proteins in
recent times have been discovered to have alternative methods of generating cofactors.
They have been able to generate active and catalytic sites by carrying out
posttranslational modifications to amino acids present within either a peptide or within a
folded protein. Amongst some of the early reported modifications in proteins was the
histidine decarboxylase. It was known that amino acid decarboxylases always contained
pyridoxal phosphate (PLP) as their cofactor. But there was an exception to this which was
found in the histidine decarboxylase. It showed the presence of a serine-derived aminoterminal pyruvoyl group37. There have also been examples of covalent linkages
12

generated by posttranslational modifications in proteins like cytochrome c oxidases that
have been found to crosslink tyrosine and histidine38, 39. Initially quinones, were known to
be involved in the transfer of electrons but was not implicated in redox proteins. Recent
crystallographic and biochemical studies have shown that some oxidoreductases have
been able to undergo posttranslational modification to generate quinones as cofactors.
These protein-derived cofactors are synthesized biologically by crosslink formation,
cyclization and oxygenation of aromatic amino acids.

Peptide-derived quinone cofactors
Pyrroloquinoline quinone (PQQ)
PQQ was first discovered in bacterial glucose dehydrogenase5. It was
generated by the posttranslational modification in glutamate and tyrosine that were
present in a precursor peptide with incorporation of the Oxygen at the Tyrosine site.
Figure 1. shows the chemical structure of the cofactor PQQ. Subsequently PQQ was
identified in different bacterial dehydrogenases such as methanol and glucose
dehydrogenase40, 41and very recently in alcohol dehydrogenase in Pseudogluconobacter
saccharoketogenes. PQQ-dependent enzymes oxidizes primary alcohols sugars and
aldehydes42. Their presence has been widely studied in prokaryotes. Most of these PQQ
containing redox enzymes have been found in the periplasmic space of gram negative
bacteria.
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Figure 1 The PQQ cofactor
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Gene products of the pqq operon has been found to be responsible for the biosynthesis
of the cofactor and these genes expressed PQQ in E.coli which doesn’t normally produce
it43. PQQ can oxidize its corresponding substrates and itself get reduced to a PQQH 2 form
by NADPH, glutathione. It can undergo oxidation again to revert to its quinone state via
the formation of superoxide radicals. PQQ has also been found in membrane-associated
dehydrogenases hence can also transfer electrons to ubiquinones attached to the plasma
membrane.
PQQ as an organic molecule has been well studied in prokaryotes but its
biosynthesis in eukaryotes and mammalian systems has not been shown. Its importance
in human system has been controversial but evidence has shown it to influence
physiological and biochemical processes. PQQ isn’t synthesized in the body but humans
are constantly being exposed to dietary sources of PQQ such as milk44, tea, green
peppers

45.

The PQQ molecule has thus been found to have different physiological

importance46. PQQ has been shown to promote cell proliferation by acting as growth
factor when added to human and mouse cell cultures 47. More recently PQQ dietary
supplements have been shown to increase mitochondrial functions and biogenesis and
an improved metabolic homeostasis48. PQQ has been shown to reduce neuronal cell
death in experimental models of stroke and spinal cord injury49, 50. Various recent work
also show multiple other functions such as redox activity, radical scavenging along with
alterations and changes in the cell signaling processes51.
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Protein-derived quinone cofactors
The discovery of PQQ led to the finding of other quinone cofactors that were
derived from posttranslationally modified amino acid residues. These cofactors were
protein-derived i.e. amino acids within the protein were modified to generate redox active
centers. The biogenesis of some of them were autocatalytic whereas some needed the
presence of another catalyzing enzyme to do so. The quinone cofactors that have been
obtained by modification of tyrosines and tryptophans are the most studied ones. The
most studied tyrosine-derived cofactors are the 2,4,5-trihydroxyphenylalanine quinone or
TPQ (Topaquinone), found mainly in copper amine oxidases and Lysine tyrosylquinone
(LTQ) found mainly in mammalian lysyl oxidases. There is also a tyrosine-cysteine crosslinked cofactor found in oxidative enzymes in mammals, yeasts and fungi52. Galactose
oxidase is known to catalyze a variety of alcohols, specifically galactose, to yield
aldehydes and H2O2. It was shown to possess this posttranslationally generated crosslink
between Cys and Tyr52.
Modifications

involving

Tryptophan

residues

resulted

in

the

generation

of

tryptophylquinone cofactors. Tryptophan tryptophylquinone (TTQ) was found in amine
dehydrogenases such as methylamine dehydrogenase (MADH) and aromatic amine
dehydrogenase (AADH), whereas the Cysteine tryptophylquinone (CTQ) was found in
quinohemoprotein amine dehydrogenase (QHNDH) and of late in the oxidases, Lysine-εoxidase (LodA) and Glycine oxidase (GoxA). Figure 2 shows the chemical structures of
the different above mentioned cofactors.
16

Figure 2. Quinone cofactors that are formed by posttranslational modifications.
CTQ is cysteine tryptophylquinone. TTQ is tryptophan tryptophylquinone. TPQ is 2,4,5trihydroxyphenylalanine quinone or topaquinone. LTQ is lysine tryptophylquinone.
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Tyrosylquinone cofactors
Topaquinone (TPQ): Most copper-containing amine oxidases were initially were thought
to contain pyridoxal phosphate PLP or PQQ. The discovery of TPQ and its extensive
characterization indicates the importance of such redox cofactors in the proteins. TPQ is
a ubiquitous cofactor that has spans over yeast, bacteria and mammals. The TPQ
containing enzymes have a wide range of functions, in bacteria it could be involved in
metabolism and in humans it could be involved in inflammatory responses. Based on the
different organs from which it has been isolated, TPQ containing enzymes have been
given various names. They include plasma amine oxidase, histamine oxidase, retinal
amine oxidase. The most studied TPQ containing enzyme has been the Copper amine
oxidase which was first discovered from bovine serum53.
TPQ is formed by posttranslational modifications in a tyrosine that was found in a
consensus site sequence of Asn-Tyr (TPQ)-Asp/Glu-Tyr54. It has been confirmed that the
synthesis of TPQ is autocatalytic in nature and is not catalyzed by another protein. Instead
an active site Copper ion present in close proximity to the Tyrosine in the TPQ, was found
to play an important part55. The holoenzyme with a completely synthesized TPQ shows
an absorption maxima at 480 nm. When the amine oxidases were synthesized in a metalfree media there was no such peak maxima, instead it just had a Tyr at the TPQ position55,
56.
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Figure 3 Proposed mechanism for TPQ biosynthesis57
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These TPQ containing oxidases have dual functions catalyzing both their own cofactor
synthesis and also substrate amine oxidation.
Figure 3 shows the mechanism of TPQ biogenesis in copper amine oxidase (CAO). The
copper amine oxidase active site is buried deep and contains a type 2 Cu(II) ion that is
bound in position by the imidazole groups of 3 His residues at a distance of around 2Å58.
In case of this oxidase the synthesis takes place in presence of Cu bound to conserved
His and other surrounding amino acids59, 60. O2 reacts with the modified Tyr which gets
deprotonated by nearby amino acids and results in the formation of dopaquinone61. There
is a charge transfer complex formation between Cu2+ and tyrosinate and generation of a
Cu+-tyrosyl radical species. O2 reacts with the intermediate to yield superoxide and reacts
with tyrosine to yield the dopaquinone. Following this there is a conformational change
which allows hydroxide to be added to it. Then the second O 2 molecule oxidizes it to form
the mature TPQ62. The copper remains bound at the site and helps in the catalysis.
Once the TPQ has been synthesized, the TPQ containing enzymes carry out the
oxidation of amines via the formation of a Schiff base. This is then followed by hydrolysis
and release of the aldehyde to produce aminoquinol63, 64. The reaction mechanism is a
ping-pong one. The oxidative half reaction is mediated by Cu and O2 by which the
aminoquinol reoxidizes to TPQ, releasing NH3 and H2O2. In humans CAOs can be found
indifferent organs and tissues such as kidney, retina and blood and is known to be
involved in cell signaling process by peroxide production65. Aberrant expression of CAO
may lead to congestive heart failure and diabetic complications by oxidative stress on
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microvascular system66. Hence the extensive characterization of the protein and its
cofactor was essential.

Lysine tyrosylquinone (LTQ): The lysine tyrosylquinone (LTQ) is the other tyrosinederived cofactor that has been studied. LTQ has been found as being an intrinsic part of
a mammalian enzyme, lysyl oxidase, being monomeric and extracellular in nature. The
enzyme catalyzes the posttranslational cross linking of elastin and collagen to form
connective tissues. It uses peptidyl lysine (i.e. lysyl residues) as its substrate and oxidizes
the residues to peptidyl-α-aminoadipic-δ-semialdehyde residues67. Lysyl oxidase is
synthesized as an initial 50kDa precursor protein which then undergoes proteolytic
cleavage to yield the catalytically active 32kDa68. This oxidase was found to be implicated
in cell proliferation and tumor suppression69 and the propeptide region before the
cleavage was thought to be responsible for this70.
The limitation in studying the LTQ was the low level of expression of the protein
and the unavailability of crystal structures. Hence using techniques like mutagenesis and
Resonance Raman spectroscopy, Tyr 349 and Lysine 314 was found to be involved in
LTQ formation71. Just like TPQ, the process of LTQ formation is also autocatalytic and
doesn’t require another protein to catalyze it72. The UV/Vis spectroscopy showed that
LTQ had an absorption maximum at 510 nm and this was 20-30 nm red shifted to TPQ
containing CAOs71. A synthetic model for LTQ, NHR-LTQ displayed a maximum at 504
nm which was in excellent accordance with the native enzyme. Since copper was present
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in the active site of this LTQ enzyme, its biogenesis was thought to be similar to that of
TPQ. The biogenesis occurred via the formation of dopaquinone followed by a
nucleophilic attack by the ε-amino group of the lysine. The fact that Cu (II) and molecular
O2 were essential for the biosynthesis of LTQ was shown by the isolation of copper
depleted form of lysyl oxidase72. An exception to this is the discovery of a lysyl oxidase
from Pichia pastoris73. Instead of having an LTQ this had a topaquinone. It was shown
that this lysyl oxidase had similar substrate specificity like the mammalian enzyme thus
concluding that the quinone cofactors were not responsible for substrate specificity.
Hence even though the mechanism of its biogenesis has been studied a detailed
investigation into the same remains to be done based on better expression systems for
the proteins.
Tryptophylquinone cofactors
The tryptophylquinone cofactor is formed by modifications at the Trp residue by
addition of Oxygen forming quinones and crosslinking with other amino acids. The two
known examples are the Tryptophan tryptophylquinone (TTQ) cofactor where it crosslinks
to another Trytophan residue and the Cysteine tryptophylquinone (CTQ) where it
crosslinks to another Cysteine residue. These tryptophylquinone cofactor containing
enzymes were in the past known to be present only in soluble enzymes that were
localized in the periplasmic space of gram negative bacteria. Unlike most of the
dehydrogenases these do not use NAD+ or NADP+ as electron acceptors. Instead they
use specific redox proteins as electron acceptors74. Methylamine dehydrogenase
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(MADH) and aromatic amine dehydrogenase (AADH) contain TTQ and quinohemoprotein
amine dehydrogenase (QHNDH) contains CTQ. In recent years 2 other quinoprotein
oxidases from Marinomonas mediterranea were found to contain CTQ, Lysine-ε-oxidase
(LodA) and Glycine oxidase (GoxA).

Tryptophan tryptophylquinone (TTQ) cofactor:
Methylamine dehydrogenase (MADH): MADH was the first known enzyme that was
found to contain TTQ75, 76. TTQ is a posttranlationally modified protein-derived cofactor
that is present as a prosthetic group77. MADH is a periplasmic protein which is known to
catalyze the oxidative deamination of methylamine to yield formaldehyde and ammonia
with transfer of electrons to another redox protein called amicyanin78. The only difference
with the aromatic amine dehydrogenase (AADH)79 is that instead of amicyanin, it is
another type 1 copper protein, azurin, that acts as the electron acceptor80. These
enzymes exist in several bacteria and allow them to use amines as a source of carbon,
nitrogen and energy. MADH uses methylamine as its substrate and the reductive reaction
begins by an adduct formation between the TTQ and amine substrate. The aminoquinol
is then oxidized by electron transfer to amicyanin, via the production of
aminosemiquinone then to the oxidized TTQ by releasing ammonia81,

82.

It has been

possible to detect the different oxidation states of TTQ. The fully oxidized TTQ shows an
absorption maxima at 440 nm, the one electron reduced semiquinone has an absorption
maxima at 428 nm and the fully reduced quinol is at 330 nm 83.
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MADH from P.denitrificans was present as a quaternary structure with 2α
subunits of 41.5 kDa each and 2β subunits of 14.4 kDa each, assembled together84. The
β-subunits have the matured TTQ. The mau operon containing mau genes, mauB and
mauA encode the α and the β subunit respectively85 and mau C encodes for amicyanin.
It has been found that the biosynthesis of TTQ is based on the expression of MauG
protein encoded by the mauG gene86. In the absence of MauG a precursor form MADH
was expressed which was called preMADH with just a single –OH group on the βTrp57
without any crosslink to βTrp10887. Crystal structure of the complex of purified MauG with
preMADH has been established in vitro depicting the formation of mature TTQ88. Figure
4A shows the conversion of the corresponding Trp to the matured TTQ form catalyzed by
MauG and 4B shows the crystal structure of the complex. This is interesting as crystal
structure of the complex could only be obtained when the 2 purified proteins were
incubated together and not from the expression system itself.
The TTQ biogenesis catalyzed by MauG has been completely and very well
characterized. MauG is a c-type diheme enzyme that catalyzes the 6-electron oxidation
in three, 2 electron steps89. The steps involved are the crosslink formation between the 2
Trp residues, the hydroxylation of the βTrp57 to form a quinol and then the oxidation of
the quinol to quinone90. It is mediated by the hemes one of which is high spin (5coordinate) and low spin (6-coordinate) thus forming a bis-Fe-(IV) state by either O2 or
addition of H2O291,

92.

By site directed mutagenesis studies it was also found that

conserved Trp93 between the 2 hemes allowed facile transfer of electrons between
them91.
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Figure 4 MauG catalyzed TTQ biosynthesis.
A. shows the chemical representation of MauG catalyzing the addition of Oxygen and the
crosslinking with Trp in presence of [O] or oxidizing equivalents. B. The crystal structure
of the complex of MauG in pink with β-subunits of preMADH, the α-subunits are shown in
blue. The βTrp57, β-Trp108 and the hemes are shown in black57. The PDB ID for this
structure is 3L4M.
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Since the dihemes are at a distance of 40 Å from the TTQ generation site, the mechanism
took place by a hopping mechanism of electron transfer instead of electron tunneling as
normally observed for short distances. This transfer of electrons between the heme and
the Trp of the preMADH occurred via the Trp199 residue93, 94. Asp32 and Asp76 have
been implicated in their involvement in the biogenesis of TTQ by preventing the proper
alignment of the active site residues and preventing the initial hydroxylation 95.
The other TTQ containing protein was the aromatic amine dehydrogenase
which was first discovered in Alcaligenes faecalis, a gram negative bacteria79. Just like
MADH, it too had 2 subunits with the TTQ being present in the smaller one. The different
redox states of TTQ were similar to that in MADH showing similar absorption spectra for
the 3 states. Even though MADH catalyzes the oxidative deamination of methylamine and
the AADH does the same for aromatic amines, their overall mechanism for the reductive
half reaction is similar. AADH was also found to react with primary aliphatic amines
especially the long and hydrophobic ones96.

Cysteine tryptophylquinone (CTQ):
Quinohemoprotein Amine Dehydrogenase (QHNDH): CTQ was first discovered in
quinohemoprotein amine dehydrogenase (QHNDH). It is a periplasmic protein and has
been isolated from P. putida97 and P. denitrificans98, the latter being also common for
MADH expression. Expression of the protein takes place in the presence of long carbon
chain substrates such as butylamine and also benzylamine which is used up as a source
of energy99. Based on their source, QHNDH uses either azurin or cytochrome c as its
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electron acceptor the latter transferring electrons to cytochrome c oxidase present as a
part of the respiratory chain100. Even though MADH and QHNDH were isolated from the
same bacterium, they were found to have structural differences. MADH was a homodimer
whereas the crystal structure of QHNDH established that it was a heterotrimeric protein
with αβγ subunits9, 101.
The largest α subunit has 2 heme c groups and the smallest γ subunit has the
CTQ cofactor along with additional crosslinks between three other Cys residues to the
carboxylic acid of either a glutamate or aspartate101. The cofactor formation involves the
Trp 43 and Cys 31 in the γ subunit102.
Unlike the biogenesis of TTQ, the biogenesis of CTQ has not been wellunderstood due to structural complexities. An idea was that an AslB-like protein encoded
by ORF2 was responsible for oxidizing the Trp 43 residue 101. AslB is a Fe-S protein that
is required for the oxidation of serine and cysteine residues in sulfatases103. On the other
hand the presence of 2 heme c groups in the α-subunit resembling the MauG protein
could also be involved. In recent years, QhpG, a Flavin dependent monooxygenase,
encoded by the qhpG gene, has been shown to possess sequence similarity with LodB
and could be involved in catalyzing the initial hydroxylation at the Trp residue 104. Due to
the presence of 3 redox centers and the very high extinction coefficient of the heme
groups, it was very difficult to measure the Em values of them. It was only achieved after
dissociating the γ subunit from the rest of the protein105. In order to aid in the
spectroscopic characterization and the kinetic studies, a model compound of CTQ having
the same indole-6,7-quinone skeleton with a thioether group at C-4 position was
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synthesized106. QHNDH has been used for the bioelectrocatalytic detection of histamine
using its native electron acceptor cytochrome c-550107. Even though the overall structure
of MADH and QHNDH are different, there is some similarity in the Asp residues at the
active site that are conserved. Asp 33 of the γ-subunit of QHNDH corresponds to the Asp
76 of the MADH β-subunit. The Asp 13 of the γ subunit of QHNDH corresponds to the
Asp 32 of the MADH.
Hence amongst the known tryptophylquinone cofactors, CTQ hasn’t been
characterized completely. Its mechanism of biogenesis and catalysis hasn’t been
elucidated completely. In this study the characterization of structural and functional
relationship in 2 unique tryptophylquinone cofactor containing oxidases have been
elucidated.

Lyinse-ε-oxidase (LodA): All previous amino acid oxidase have been known to be
flavoproteins108 and catalyze the oxidative deamination of amino acids to generate α-keto
acids, ammonia and hydrogen peroxide. The amino acid oxidation takes place at the αposition of the amino acid chain. The most characterized one are the ones from the snake
venom109. The release of H2O2 determines the ability of the protein to execute
antimicrobial functions110. Often peptides and proteins have been shown to have
antimicrobial properties. In various higher organisms they act as a defense mechanism
against pathogens111. Many of these LAOs have been found in microorganisms and their
antimicrobial activity gives them an added advantage over competing strains 112. One of
the most studied LAO, is the L-lysine-α-oxidase113. Since L-lysine is an essential amino
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acid that cannot be synthesized in the body, enzymes that are capable of cleaving these
have been investigated in context of their possible application in oncology114.
Comparative studies of LodA with the L-lysine-α-oxidase and lysl oxidase have also been
done. L-lysine-α-oxidase is a flavoprotein. Even though it resulted in a much higher
hydrogen peroxide generation, the Km for L-lysine was 40µM115. The kinetic parameter
thus indicated that L-lysine-α-oxidase was not specific for L-lysine as its substrate and
could use other amino acids as well.
For the first time in a melanogenic marine bacterium, Marinomonas
mediterranea116, an L-amino acid oxidase was found that contained a quinonic cofactor
and not a Flavin117. It was called the Lysine-ε-oxidase, LodA. Unlike the other
flavoproteins this did not have any FAD binding site118. It also differed from the others as
the amino acid oxidation that it catalyzed was at the ε-position instead of the very common
α-position. The oxidative deamination leads to the generation of a semialdehyde,
ammonia and hydrogen peroxide. Due to the release of the latter, it has been found to be
antimicrobial against both the gram positive and the gram negative bacteria 119. LodA is
secreted, thus helping in the differentiation and dispersal of biofilms by forming
microcolonies due to its antimicrobial nature120. It showed much higher affinity and
specificity for L-lysine than that shown by the L-lysine-α-oxidase. The reason for this is
the that the available concentration of free amino acids in marine water is very low,
therefore the Km for L-lysine has been adapted accordingly
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A.

B.

Figure 5 Shows the crystal structure of LodA. (PDB ID 2ymw).
A. show the whole protein as crystallized with the CTQ cofactors. B. Shows the enzyme
active site with the Cys 516 and the Trp 581 residues.
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Sequence analysis shows the presence of 2 ORFs in an operon-like fashion121. The first
one which was the larger one encoded a 726 amino acid protein of a mass of around
76kDa. This was the LodA. It was seen that Cysteine 516 and Trp 581 did undergo
posttranslational modifications to form the CTQ cofactor. Three different crystal structures
have been reported, PDB ID – 2YMW, 3WEU122, 3WEV. Figure 5A. shows the reported
crystal structure for LodA and B. shows the active site with the modified CTQ cofactor.
The second ORF which was 2bp from the stop codon of lodA, encoded a protein of 369
amino acid and with an approximate molecular mass of 41.4kDa.This was LodB, which
had a putative FAD binding domain123. It has been shown that LodB is absolutely required
for the expression of the mature CTQ containing LodA124, hence indicating that the
posttranslational modification of the Cys and the Trp residue could be an FAD-mediated
process.
Until the discovery of LodA, only amine dehydrogenases were known to contain
tyrptophylquinone cofactors. This was the first example of an oxidase showing an unusual
cofactor. Hence crystal structure overlays were done with both MADH (TTQ containing)
and QHNDH (CTQ containing) to see how the structures correlated. Various residues
were found to be analogous to the active site Aspartates of MADH and QHNDH some of
which have been shown to be involved in cofactor biogenesis and substrate specific. The
presence of Asp 512 in LodA corresponding to the Asp 76 (MADH) and Asp 32 (QHNDH)
shows possible conserved function in functionally different proteins. Figure 6A shows the
overlay of MADH with LodA and the corresponding cofactor and active site residues, B.
shows the overlay of QHNDH with LodA.
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A.

B.

Figure 6 Overlay of reported crystal structures of LodA, MADH, QHNDH.
A. overlay of MADH and LodA with the cofactor forming and active site residues. B.
overlay of LodA and QHNDH highlighting the same.
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Recent genome sequencing studies on Marinomonas mediterranea showed the presence
of 2 such similar genes which are both followed by lodB-like genes. A wider genome
sequencing was done to get an idea about the distribution of these LodA-like proteins. It
was found that 168 such similar genes were present in 144 different microbial genomes
including some fungal ones. LodA-like proteins were categorized under group IA and a
detailed look into their sequence shows the conserved Cys and Trp generating CTQ. All
of them are oxidases and are expressed in organisms known for antimicrobial
properties125.

Glycine oxidase (GoxA): Based on the genome analysis of Marinomonas mediterranea,
2 other genes were identified that showed similarity to lodA126. One of them was thought
to show glycine oxidase activity and was called GoxA14. It too had another gene
downstream and overlapping the stop codon for goxA which encodes a second LodB-like
GoxB protein which too is a flavoprotein. This glycine oxidase contains a quinone cofactor
formed from Cys 551 and Trp 566 determined from sequence alignments. This is different
from all other known glycine oxidases (GO). The GO from Bacillus subtilis is a 45kDa
flavoenzyme containing non-covalently bound FAD127. This GO was found to carry out
the oxidative deamination of a wide range of substrates in order to form the α-keto acids.
The GoxA discovered in the marine bacterium did not contain a Flavin cofactor and was
specific for Glycine as its substrate.
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Figure 7 Homology model of GoxA monomer with the highlighted Cys 551 and Trp 566
involved in CTQ biosynthesis.
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The crystal structure of GoxA has not been reported. But homology models have been
constructed to give an idea about the possible protein structure. Figure 7 shows the
homology model of GoxA with the Cys and Trp that form the cofactor.
GoxA catalyzes the following reaction:
Glycine + O2 + H2O → glyoxylate + NH3 + H2O2

(2.1)

It generates peroxide but it isn’t known if that is the only physiological function that it
possess. Phylogenetic and sequence analysis done on microbial genomes have put
GoxA in group II for the Lod-like proteins125. LodA and GoxA have been shown to possess
22.8% identity and 34.6% identity.
It has been shown that in the absence of the GoxB and the LodB proteins, an
incompletely modified CTQ is synthesized in GoxA and LodA respectively and the roles
of the B protein are not interchangeable. The precursor protein that is generated in the
absence of GoxB and LodB contains a single hydroxylation at the Trp residue11. and the
mass spec of the precursor LodA shows an increase of 16 instead of 28 for a fully formed
CTQ128.
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CHAPTER 3: STEADY-STATE KINETIC MECHANISM OF LODA, A NOVEL
CYSTEINE TRYPTOPHYLQUINONE- DEPENDANT OXIDASE
FEBS Lett. 2014 Mar 3;588(5):752-6
Introduction
LodA is a novel lysine-ε-oxidase which was recently found in the melanogenic
marine bacterium, Marinomonas mediterranea129-131. This enzyme was originally called
marinocine but is now referred to as LodA, the gene product of lodA. LodA exhibits
antimicrobial properties in vivo that result from its production of H2O2. It is secreted to the
external medium in the biofilms in which the bacterium resides. This causes death of a
subpopulation of cells within the M. mediterranea biofilm that is accompanied with
differentiation, dispersal and phenotypic variation among dispersal cells 10.
Typical amino acid oxidases utilize a flavin cofactor for catalysis and act upon
the α-amino group. LodA removes the ε-amino group of lysine and the recent crystal
structure of LodA reveals that it contains a cysteine tryptophylquinone (CTQ) cofactor132.
CTQ is a protein-derived cofactor57, which is generated by the posttranslational
modification of cysteine 516 and tryptophan 581 of LodA. Analysis of LodA by mass
spectrometry yields a molecular mass that is also consistent with the presence of CTQ128.
Another protein LodB is required for the posttranslational formation of CTQ124, 128. All other
tryptophylquinone cofactor-containing enzymes are dehydrogenases that use other redox
proteins as their electron acceptors133; this is the first time that one has been shown to
function as an oxidase. The best known tryptophylquinone enzymes possess tryptophan
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tryptophylquinone (TTQ, Fig. 1) where the modified Trp is cross-linked to another Trp
rather than a Cys77. The known TTQ enzymes are primary amine dehydrogenases57, 134.
The one other CTQ-dependent enzyme that has been characterized is a
quinohemoprotein amine dehydrogenase (QHNDH) which possesses two covalently
attached hemes in addition to CTQ9, 101.
Another class of protein-derived cofactors that contain quinones derived from
Tyr residues has been identified135. These possess the topaquinone (TPQ, Fig. 1)
cofactor and are found only in primary amine oxidases. In each case, these enzymes also
possess a tightly bound copper in the active site which is required for biogenesis of the
cofactor and subsequently participates in catalysis. A related cofactor is lysine
tyrosylquinone (LTQ) which is the catalytic center of mammalian lysyl oxidase71. This
enzyme is also a lysine ε-oxidase but it acts only on lysyl residues of a protein substrate
rather than free lysine67. Like the TPQ-dependent enzymes, lysyl oxidase also possesses
a tightly-bound copper in the active site72. LodA is the first example of an amino acid or
primary amine oxidase that contains neither a flavin nor a metal at its active site.
This paper presents a steady-state kinetic analysis of the reaction that is
catalyzed by LodA (eq 1) to determine its steady-state reaction mechanism and kinetic
parameters. The results are used to propose a reaction mechanism which is consistent
with the crystal structures of a lysine-bound adduct of LodA132.
L-lysine + O2 + H2O → 2-aminoadipate 6-semialdehyde + NH3 + H2O
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(3.1)

LodA is a novel lysine-ε-oxidase which possesses a cysteine tryptophylquinone cofactor.
It is the first tryptophylquinone enzyme known to function as an oxidase. A steady-state
kinetic analysis shows that LodA obeys a ping-pong kinetic mechanism with values of kcat
of 0.22±0.04 s-1, Klysine of 3.2±0.5 μM and KO2 of 37.2±6.1 μM. The kcat exhibited a pH
optimum at 7.5 while kcat/Klysine peaked at 7.0 and remained constant to pH 8.5. Alternative
electron acceptors could not effectively substitute for O2 in the reaction. A mechanism for
the reductive half reaction of LodA is proposed that is consistent with the ping-pong
kinetics.
Materials and Methods
Recombinant LodA was expressed in E.coli Rosetta cells which had been
transformed with pETLODAB128 which contains lodA with an attached 6xHis tag and lodB
which is required for the posttranslational modification of LodA that forms CTQ. The cells
were cultured in LB media with ampicillin and chloramphenicol. Expression levels of
active LodA are very sensitive to induction conditions and previously determined optimal
conditions128 were followed. When the absorbance of the culture reached a value of 0.6,
the temperature was decreased to15 ˚C and cells were induced by addition of 1 mM IPTG.
Cells were harvested after 2 hr and then broken by sonication in 50 mM potassium
phosphate buffer (KPi), pH7.5. The soluble extract applied a Nickel-NTA affinity column
and the His-tagged LodA was eluted using 100-120 mM imidazole in 50 mM KPi, pH 7.5.
LodA was then further purified by ion exchange chromatography with DEAE cellulose in
50 mM KPi, pH 7.5. The His-tagged LodA bound to the resin and was eluted using 180-
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270 mM NaCl in the same buffer. The protein was judged pure by SDS-PAGE and its UVvisible absorption spectrum exhibited a broad peak centered at 400 nm with an
absorbance at 400 nm which was about 13-fold less intense than the absorbance at 280
nm. Methylamine dehydrogenase (MADH)136, amicyanin78 and cytochrome c-550137 were
purified from Paracoccus denitrificans as described previously.
LodA activity had previously been assayed using a standard coupled assay for
oxidases in which horseradish peroxidase (HRP) is also present and uses the H 2O2
product of the oxidase reaction to oxidize Amplex Red to resorufin which leads to a
change in fluorescence8. This assay was modified to instead follow the change in
absorbance associated with production of resorufin which has an extinction coefficient at
of 54000 M-1 cm-1 at its absorbance maximum of 570 nm. The assay mixture contained
0.05 mM Amplex Red, 0.1U/ml of HRP and 0.4 μM LodA in 50 mM KPi, pH 7.5 at 25 ˚C.
The concentration of LodA was determined using an ε 280= 125,180 M-1cm-1 which was
calculated from its amino acid sequence138. Experiments were performed in which [lysine]
was varied in the presence of fixed concentrations [O 2] and vice versa. To vary the
concentration of O2, an appropriate amount of a stock solution of air-saturated buffer
([O2]=252 μM) was mixed with the reaction mixture which had been made anaerobic by
repeated cycles of vacuum and purging with argon. The reactions were initiated by the
addition of lysine. In order to account for a small background reaction in which Amplex
Red is spontaneously converted to resorufin, control experiments were performed in the
absence of LodA to determine the background rate which was subtracted from the
experimentally-determined LodA-dependent reaction rates. The reaction was also
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assayed by monitoring the release of the ammonia product using a coupled assay. The
assay mixture contained 20 U/ml glutamate dehydrogenase, 5 mM α-ketoglutarate, 0.4
μM LodA and 93.7 μM NADH in 50 mM KPi, pH 7.5 at 25 ˚C and the reactions were
initiated by the addition of lysine. In assays to test the reactivity of artificial electron
acceptors the assay mixture contained 0.4 μM LodA in 50 mM KPi, pH 7.5 at 25 ˚C under
anaerobic conditions. The reaction was initiated by addition of lysine and monitored by
the spectral change associated each electron acceptor, phenazine ethosulfate (PES) plus
2,6-dichloroinophenol (DCIP) (ε600=21,500 M-1cm-1), ferricyanide (ε420=1,040 M-1cm-1), or
NAD+ (ε340=6,220 M-1cm-1), amicyanin (ε595=21,500 M-1cm-1), cytochrome c-550
(ε550=30,200 M-1cm-1).
Results and Discussion
Steady-state reaction mechanism and parameter
Steady-state assays of lysine oxidation by LodA were performed in order to
determine the kinetic mechanism of this reaction and the kinetic parameters that describe
this reaction. The initial rates of reaction were determined at different concentrations of
lysine in the presence of a series of fixed concentrations of O 2 (Fig. 8A). Double reciprocal
plots of these data exhibited a series of lines which are clearly more parallel than
intersecting, consistent with a ping-pong mechanism rather than an ordered or random
sequential mechanism (Fig. 8B). Thus, the reaction is described by eq 2. Secondary plots
of the intercept (1/kcat apparent) versus 1/[O2] (Fig. 8C) and intercept/slope (1/Klysine
apparent) versus 1/[O2] (Fig. 8D) were each linear. These plots are described by eqs 3
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and 4(), respectively. Similarly, when the initial rates of reaction were determined at
different concentrations of O2 in the presence of a series of fixed concentrations of lysine
a series of parallel lines was obtained in the reciprocal plots and secondary plots were
linear (Figures 8E and 8F) and analysis yielded similar values of Kcat = 0.22 ± 0.04 s-1, Km
for lysine is 3.2±0.5 μM, Km for O2 is 37.2±6.1 μM .

kcat[lysine][O2]
v/E =

———————————————————

(3.2)

Klysine[O2] + KO2[lysine] +[lysine][O2]

intercept = (KO2/ kcat) (1/[O2]) + (1/ kcat)

(3.3)

intercept/slope = (KO2/ Klysine) (1/[O2]) + (1/ Klysine)

(3.4)

This reaction was also studied using another coupled enzyme assay in which the
rate of formation of the ammonia product was coupled to NADH oxidation by glutamate
dehydrogenase in the presence of α-ketoglutarate. When the assay was performed using
saturating concentrations of 100 μM lysine and 252 µM O 2 the rate of reaction was
0.25±0.07 s-1which is within experimental error of the kcat value obtained in the assay
which monitored H2O2 production.
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Figure 8 Steady-state kinetic analysis of LodA.
A. Initial rates were determined at different concentrations of lysine in the presence of a
fixed concentration of 252 (○), 129 (♦), 54 (▼), 11 (▲) or 5 (●) µM O2. B. Double reciprocal
plot of the data shown in panel A. C. Secondary plots of the y-intercept (1/apparent kcat)
from panel B versus 1/[O2]. Data are fit by eq 3. D. Secondary plots of the yintercept/slope (1/apparent Klysine) from panel B versus 1/[O2]. Data are fit by eq 4. E.
Secondary plots of the y-intercept (1/apparent kcat) from plots of v/E versus [O2] against
1/[lysine]. Data are fit by eq 3. F. Secondary plots of the y-intercept/slope (1/apparent
KO2) from plots of v/E versus [O2] against 1/[lysine]. Data are fit by eq 4.Error bars are
indicated in the secondary plots (C-F).
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Dependence of LodA activity on pH
The pH dependence of kcat and kcat/Km for lysine were determined at 252 µM O2
(Fig. 9). The kcat value exhibited a bell-shaped pH profile with a maximum at pH 7.5. This
suggests that there are at least two residues that are required and that one must be
protonated and the other must be unprotonated for catalysis. In contrast the k cat/Km values
reached a maximum at pH 7.0 and stayed relatively constant up to pH 8.5. Thus, the
catalytic efficiency of LodA is retained at the higher pH as a consequence of a decrease
in Klysine.
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Figure 9 Dependence on pH of kcat and kcat/Km for lysine at saturating concentration of
O2.
Error bars are indicated.
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Reactivity towards alternative electron acceptors.
The distinguishing property between an oxidase and a dehydrogenase is that, the
oxidases use oxygen as their final electron acceptor whereas the latter use other redox
proteins or non-protein electron acceptors other than oxygen. Since all other know
tryptophylquinone enzymes are dehydrogenases the ability of LodA to function as a
dehydrogenase was tested using alternative electron acceptors. The most widely used
assay for quinoprotein dehydrogenases uses PES coupled to DCIP. For comparison the
assay was also performed on MADH which possesses the TTQ cofactor. When assayed
in the presence of saturating methylamine with 5 mM PES and 100 µM DCIP MADH
exhibited a rate of 36 s-1 while LodA when assayed in the presence of saturating lysine
under these conditions exhibited a rate of 0.06 s-1. Another commonly used artificial
electron acceptor is ferricyanide. When similarly assayed in the presence of 1 mM
potassium ferricyanide with saturating lysine LodA exhibited a rate of 0.10 s -1. For a more
direct comparison of the efficiency of the artificial electron acceptors, the assays were
repeated using 252 µM PES or ferricyanide, a concentration equivalent to that used for
O2 (KO2 = 37.2±6.1 μM). At this concentration the rates with PES/DCIP and ferricyanide
were each 0.01 s-1 which is barely above background, compared 0.22±0.04 s-1 for O2.
NAD+ (1 mM) was also tested in the presence of 100 µM lysine and no detectable reaction
was observed. Two protein electron acceptors were also tested. The copper protein
amicyanin is the natural electron acceptor for MADH. In the steady state reaction of
methylamine dependent amicyanin reduction by MADH, amicyanin exhibits a kcat of 48 s1

and Km of 6 µm139. When LodA was assayed with 100 µM amicyanin and saturating
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lysine the rate was only 0.008 s-1. Cytochrome c-550 from P. denitrificans is a relatively
promiscuous electron acceptor that shares structural features with many bacterial and
mammalian cytochromes c140. When LodA was assayed with 100 µM cytochrome and
saturating lysine the rate was 0.002 s-1.
One cannot rule out the possibility that in vivo there is an unidentified redox-active
molecule or protein that could serve as an electron acceptor for LodA instead of O 2.
However, no significant dehydrogenase activity of LodA could be detected in this study.
These results support the proposal that the generation of H2O2 and consequent
antimicrobial activity129 is the main physiological function of LodA, which is secreted from
cell to perform this function.
Proposed mechanism
The ping-pong kinetic mechanism requires that an intermediate form of the
enzyme exist after binding of substrate and release of the first product prior to binding of
the second substrate. This finding is consistent with the reported crystal structure of LodA
with a covalent lysine adduct with CTQ132 and suggests the following reaction mechanism
(Fig. 10). The ε-amino group of lysine must first be deprotonated, likely by an active site
residue, so that the resulting nucleophilic NH2 group can attack the electrophilic carbonyl
carbon to displace the bound oxygen and yield a Schiff base intermediate, as seen in the
crystal structure. An active site residue then abstracts a proton from the ε-carbon reducing
the cofactor and resulting in the Schiff base now involving the ε-carbon. Inspection of the
crystal structure of the LodA-lysine adduct132
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reveals that the S of Cys448 is

approximately 5.5 Å from this carbon and could possibly be involved in this step. This
covalent adduct is then hydrolyzed to release the aldehyde product prior to O 2 binding.
This yields an aminoquinol intermediate form of the enzyme consistent with a ping-pong
mechanism. This proposed mechanism for this reductive half-reaction is essentially
identical to those of QHNDH102 and MADH139, which possess CTQ and TTQ, respectively.
It is also the same mechanism proposed in the reductive half-reactions of the TPQdependent amine oxidases141. With the TTQ-dependent MADH it was shown that the
ammonia product was not released until after the quinol was oxidized to the quinone by
its electron acceptor, and that in the steady-state this occurred by displacement of the
amino group from the cofactor by the next amine substrate molecule 102. This may be true
for LodA as well. Alternatively, it could be hydrolyzed by water. A key question which
remains unanswered is how the quinol or aminoquinol in LodA is reoxidized by O 2. In the
TPQ-dependent oxidases Cu2+ is also present at the active site. It has been proposed
that this interacts with the quinol intermediate to yield a Cu +-semiquinone intermediate
which would allow reaction of the Cu+ with oxygen to generate a superoxide species in
the first step of the reoxidation142, 143. LodA, however, does not have a bound metal.
Future characterization of the mechanism of the oxidative half-reaction of LodA should
be of great interest.
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Figure 10. Proposed mechanism for LodA-catalyzed oxidative deamination of
lysine.
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CHAPTER 4: ROLES OF ACTIVE SITE RESIDUES IN LODA, A CYSTEINE
TRYPTOPHYLQUINONE DEPENDENT LYSINE-Ε-OXIDASE
Arch Biochem Biophys. 2015 Aug 1;579:26-32
Introduction
LodA (previously called marinocine) is an ε-lysine oxidase that was first discovered
in Marinomonas mediterranea, a melanogenic marine bacterium8, 129, 130. It catalyzes the
oxidative deamination of lysine by removing the ε-amino group and releasing the
aldehyde product plus hydrogen peroxide (eq 1). When secreted out into the biofilm in
which the bacterium resides, LodA exerts antimicrobial activity as a consequence of the
production of H2O2. This is beneficial because causing death of a subpopulation of cells
facilitates biofilm differentiation and dispersal of surviving cells with phenotypic variation
among dispersed cells10. Wild type (WT) LodA has been recombinantly expressed in E.
coli128 and isolated. LodA contains a protein-derived cofactor6 which is generated by
posttranslational modifications. The cofactor is cysteine tryptophylquinone (CTQ) which
is formed by the di-oxygenation of Trp581 and the crosslinking of this residue with
Cys516. Expression of active LodA with correctly synthesized CTQ requires the coexpression of the lodB gene128, which encodes a flavoprotein that is required for the
posttranslational modifications that generate CTQ.
Lysine + O2 + H2O → 2-aminoadipate 6-semialdehyde + NH3 + H2O2
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(4.1)

LodA is the first enzyme that was shown to use a tryptophylquinone cofactor that
functions as an oxidase. All previously described enzymes that use CTQ or tryptophan
tryptophylquinone (TTQ) cofactors are dehydrogenases that use other redox proteins or
small molecules other than NAD(P)+ as electron acceptors133. LodA is distinct from the
other known tryptophylquinone enzymes in using an amino acid as a substrate. LodA is
also unusual among amino acid oxidases since the other enzymes previously described
in this group utilize a flavin cofactor. Three crystal structures of LodA have been
determined, LodA isolated from M. mediterranea alone (PDB 3WEU) and with the lysine
substrate covalently-bound to CTQ (PDB 3WEV)132, and recombinant LodA isolated from
E. coli (PDB 2YMW). Inspection of these structures identified the residues which are
modified to form CTQ, Trp581 and Cys516. It was subsequently shown that mutation of
either of these two residues to Ala resulted in no CTQ biosynthesis11. It was also shown
that conversion of Asp512, which is in close proximity to CTQ, to Ala led to expression of
a precursor of LodA without CTQ11. A similar effect was reported when the structurally
analogous Asp was mutated in methylamine dehydrogenase (MADH). That led to
expression of a precursor of MADH without TTQ95.
A steady-state kinetic study showed that LodA follows a ping-pong mechanism in
which it first interacts with lysine forming a Schiff base intermediate with CTQ, then
releases the aldehyde product, and then binds O 2 to finally release NH3 and H2O212.
(Figure 12). From the structure of LodA it was also possible to identify other residues of
interest in the active site of LodA which could participate in binding of one or both
substrates, or catalysis, as well as CTQ biosynthesis (Figure 11). These residues are the
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topic of this study. Cys 448 is located in close proximity to the quinone oxygens of CTQ.
Two other quinoproteins, the CTQ-containing quinohemoprotein amine dehydrogenase
(QHNDH)101 and the TTQ-containing MADH144, have a structurally conserved Asp residue
in the position corresponding to Cys448 in the LodA structure in the active site. Mutation
of the corresponding Asp in MADH affected the efficiency of MauG-dependent TTQ
biosynthesis but had no effect on the catalytic activity of the population of the isolated
MADH with fully formed TTQ95. As such, Cys448 in LodA was converted to Asp, as well
as Ala, to ascertain its role in CTQ biosynthesis or catalysis or both. Tyr211 resides in a
loop comprised of residues 206 to 215, and it is flanked by one and three Gly residues on
either side. This loop which is located close to the entrance of the active site was not
visible in the crystals structures of the free and substrate bound native enzymes. In the
structure of recombinant LodA, this loop was defined in the structure of one of the two
molecules in the asymmetric unit but not in the other. These observations are consistent
with mobility of this loop and a possible role in controlling substrate binding or product
release, or both, from the active site. To probe the role of Tyr211 it was converted to Phe,
Ala and Glu. Lys530 is of interest because it appears to form a hydrogen bond (2.7 Å)
between its ε-amino N and the phenolic O of Tyr211. It was converted to Ala and Arg.
The results of this study demonstrate that these residues in the active site of LodA play
multiple roles in binding of lysine and O2, catalysis and CTQ biosynthesis. Analysis of the
Integrated Microbial Genomes database of genome sequences identified 168 genes from
144 different bacterial sequences that encoded LodA-like proteins125. LodA from M.
mediterranea was classified as a member of Group IA LodA-like proteins. The residues
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which were mutated in this study were highly conserved in these sequences. These
results are discussed in the context of the different evolutionary factors that must be
considered for enzymes which possess protein-derived cofactors, in which the catalytic
cofactor must be generated by posttranslational modifications.
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Figure 11 Residues of interest in the active site of LodA.
A portion of the structure of LodA (PDB entry 2YMW) is shown with the residues that form
CTQ and other residues of interest in the active site shown as sticks
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Figure 12 Reaction mechanism for the LodA-catalyzed oxidative deamination of
lysine.
Represents an active-site residue which participates in acid–base chemistry
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Materials and Methods

Construction, expression and purification of recombinant proteins.
Wild-type (WT) LodA and LodA variants that were generated by site-directed
mutagenesis were expressed in E. coli Rosetta cells as described previously with the lodB
gene co-expressed12,

128.

The recombinant LodA possessed a 6XHis tag to facilitate

purification as previously described12. The following LodA variants were generated by site
directed mutagenesis: C448A, C448D, Y211A, Y211E, Y211F, K530A and K530R. The
forward and reverse primers that were used are shown in Table 1. Most of the mutations
were made using the QuikChange Lightning kit. The Y211A and C448A mutations were
constructed using the overlapping extension method. In the latter case, pETLODAB15
was used as a template for the mutagenesis PCR128 using Pfu DNA polymerase
(Promega). The outer primers used to perform the last PCR step containing the mutations
were

MARDIRsac1

(5’-CTCTGGTGAGCTCCTACAG-3)

and

MAREVeco2

(5’-

GTGCTTGGGAGAATTCGCCTC-3’). After PCR amplification, fragments were cloned
using the SacI-SacII sites in pETLODAB15, substituting the wild type copy of lodA. All
mutations were confirmed by automated DNA sequencing. All cloning steps were
performed using E. coli DH5α and the plasmids obtained were electroporated or
transformed into E. coli Rosetta just before induction.
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The concentration of purified LodA was determined using an ε 280= 125,180 M-1cm-1 which
was calculated from its amino acid sequence138.
Steady-state kinetic analysis.
The steady-state activity of ε-lysine oxidase was monitored using a coupled assay
that included horseradish peroxidase (HRP), which uses the H2O2 product of the reaction
to oxidize Amplex Red to resorufin, which has an extinction coefficient of 54000 M-1cm-1
at 570 nm12. The assay mixture contained 0.05 mM Amplex Red, 0.1 U/ml of HRP and
0.42 µM LodA (WT or variants) in 50 mM potassium phosphate buffer, pH 7.5, at 25 ˚C
with the indicated amounts of lysine and O2 included. To vary [O2] the buffer was made
anaerobic by repeated cycles of vacuum and purging argon and mixed with an
appropriate amount of air saturated ([O2]=252 µM) or 100% O2-saturated ([O2]= 1150 µM)
buffer145. In order to investigate the possibility that any of the mutations had converted
LodA from an oxidase to a dehydrogenase, reactions were also performed under
anaerobic conditions using artificial electron acceptors as described previously12. In these
cases the reaction was initiated by addition of lysine and monitored by the spectral change
associated each potential electron acceptor, phenezine ethosulfate (PES) plus 2,6dichloroinophenol (DCIP) (ε600=21,500 M-1cm-1), ferricyanide (ε420=1,040 M-1cm-1), or
NAD+ (ε340=6,220 M-1cm-1). The data were fit by eq 2.
v/E = kcat[S]/([S] + Km)

(4.2)
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Estimation of the extent of CTQ biosynthesis.
The absorption spectrum of the purified oxidized form of active LodA exhibits
characteristic features in the 350-450 nm range (Figure 13A). Inspection of the absorption
spectra of the purified variant enzymes revealed the ratio of absorbance at 400 nm to
absorbance at 280 nm (A400/A280) was affected by some of the mutations, despite the fact
that proteins were pure as judged by SDS-PAGE. The features of the absorption spectra
of the variants are essentially identical to that of WT LodA except for the intensity (Figure
13B). The most likely explanation for this is that some mutations affect the extent to which
CTQ biosynthesis has occurred, yielding a mixed population of active LodA with mature
CTQ and inactive preLodA with incompletely synthesized CTQ. Unfortunately, it was not
possible to verify this by determining a molar extinction coefficient for CTQ in LodA by
performing a spectrochemical quantitative redox titration because of poor reactivity of the
protein-bound CTQ towards dithionite and other reductants. For ease of comparison, the
ratio of A400/A280 for each variant is presented, normalized with the value for WT LodA set
as 1.0 (Table 2). To be sure that the A400 was not varying due to changes in the activesite environment that were caused by mutations, the ratio of A 400/A280 was also
determined for proteins after incubation in 6 M guanidine HCl. The values for these
unfolded proteins were the same as for the native proteins indicating that the ratio of
A400/A280 was a valid indicator of the extent of CTQ biosynthesis. For determination of kcat
values, the concentration of enzyme was determined from A280. As such one may wish to
adjust the kcat values for variants with normalized A400/A280 values greater or less than
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1.0. The Km values will not be affected by the variation in A 400/A280 since the
experimentally determined Km is not dependent on the concentration of the enzyme.

Sequence alignments of LodA-like proteins.
LodA-like proteins belonging to group IA, as defined previously138 includes LodA
and the most similar proteins. The proteins in this group were aligned using the program
clustal omega [17] available at http://www.ebi.ac.uk/Tools/msa/clustalo/.
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Table 1: Primers used to generate site-directed mutations

Mutation Primers
C488A

forward 5’-GTTGGATTGCCTATGGCTCCAGGAATAGAAATG-3’
Reverse 5’-CATTTCTATTCCTGGAGCCATAGGCAATCCACC-3’

C448D

forward: 5’ GATTGCCTATGGATCCAGGAAT 3’
reverse: 5’ ATTCCTGGATCCATAGGCAATC 3’

Y211A

forward 5’-CAGATCTCAGCGGTGCTGGTGGTGGAGATGA-3’
Reverse 5’-TCATCTCCACCACCAGCACCGCTGAGATCTG-3’

Y211E

forward: 5’ GATCTCAGCGGTGAAGGTGGT 3’
reverse: 5’ ACCACCTTCACCGCTGAGATC 3’

Y211F

forward: 5’ GATCTCAGCGGTTTTGGTGGT 3’
reverse: 5’ ACCACCAAAACCGCTGAGATC 3’

K530A

forward: 5’ AGCGTCAATGCAGCAAGTCAG 3’
reverse: 5’ CTGACTTGCTGCATTGACGCT 3’

K530R

forward: 5’ AGCGTCAATCGAGCAAGTCAG 3’
reverse: 5’ CTGACTTGCTCGATTGACGCT 3’
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Table 2 Steady-state kinetic parameters for LodA variants
Normalized
value

kcat (s-1)b

Km lysine (µM)

Km O2 (µM)

of A400/A280a
WT LodA

1.0

0.34 ± 0.01

3.9 ± 0.2

199 ± 20

C448A LodA

1.0

0.39 ± 0.02

48 ± 4

543 ± 94

C448D LodA

1.5

0.29 ± 0.03

142 ± 33

386 ± 70

129 ± 22

522 ± 162

(0.19)
Y211F LodA

0.8

0.19 ± 0.02
(0.23)

Y211A LodA

1.5

No reaction

No reaction

No reaction

Y211E LodA

1.5

No reaction

No reaction

No reaction

K530A LodA

0.7

1.2 ± 0.1

52 ± 5

1043 ± 102

113 ± 13

706 ± 95

(1.7)
K530R LodA

0.3

0.68 ± 0.04
(2.3)
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Figure 13 The absorbance spectra of WT LodA and LodA variants.
A. The absorbance spectrum of WT LodA with the visible absorbance features of CTQ
magnified in the inset. B. The visible absorbance spectra of LodA variants in this study.
The 280 nm absorbance in each of these spectra is identical so the observed variations
in the intensity of the absorbance reflect the variation in A 400/A280 nm of these variant
proteins. The spectra from top to bottom are C448D, Y211A, Y211E, WT, C448A, Y211F,
K530A and K530R LodA.
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Results
Modification of the steady-state assay conditions to allow comparison of LodA
variants.
In the previous steady-state kinetic study of LodA, the maximum concentrations of
lysine and O2 that were used were 30 µM and 252 µM, respectively12. Those values were
well above the Km values that were determined for each substrate. Preliminary
examination of the LodA variants which are the topic of the current study revealed that
some of them exhibited significantly greater Km values for these substrates. In order to
obtain reasonable estimates for the Km and kcat values for these variants, it was necessary
to extend the range of substrate concentrations used to 1 mM for lysine and 1150 µM for
O2 (100% O2 saturation). In the presence of 1150 µM for O 2, the reaction with WT LodA
exhibited values of kcat of 0.34 ± 0.01 s-1, Km for lysine of 3.9 ± 0.2 µM. These values of
kcat and Km for lysine are similar to the previous reported values of 0.22 ± 0.04 s-1 and 3.2
± 0.2 µM, respectively12. However in the presence of 1 mM for lysine, a Km for O2 of 199
± 20 µM was obtained which is larger than the previously reported value of 37 ± 6 µM.
The reason for this discrepancy is unclear. It may be an artifact caused by the very high
lysine concentration which is required to study the variants. It is possible that lysine is
binding non-specifically to the enzyme, or perhaps competing with the other substrate
(O2) in the ping-pong mechanism. Despite this peculiarity, in this study all LodA variants
and WT LodA were analyzed at the higher concentration ranges so that the values of the
kinetic parameters for each enzyme could be compared under the same conditions.
Furthermore, as a consequence of some of the mutations, the apparent Km for O2
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approached the [O2] in 100% O2-satuated buffer. As, such it was not possible to perform
experiments in which [O2] could be varied over an appropriate range so as to obtain true
kinetic parameters. As a consequence of this, the Km values that are reported here should
be considered apparent Km values. However, as can be seen in the results which follow
(Table 2), the effects of these mutations on kinetic parameters are quite evident and so
the conclusions that can be drawn from these results are not compromised by these
limitations imposed by the experimental system.
Effects of Cys448 mutations
Cys448 is present at the active site of LodA in close proximity (5.3 Å) to the CTQ
cofactor. This residue was of particular interest because in the TTQ-dependent MADH,
mutation of an Asp residue which occupies the analogous position near TTQ in the active
site, to Asn caused decreased efficiency of TTQ biosynthesis95. C448A and C448D LodA
mutations were made and each of these variant proteins was expressed and isolated at
yields comparable to that of the WT LodA. The C448D LodA mutation actually increased
the A400/A280 ratio of the purified protein. This suggests that WT LodA contains a
subpopulation with incompletely biosynthesized CTQ and that introducing Asp at this
position in LodA has enhanced the efficiency of CTQ biosynthesis relative to WT LodA.
The C448A and C448D LodA variants each exhibited lysine oxidase activity
(Figure 14, Table 2). The kcat values of 0.39 ± 0.02 s-1 for C448A LodA and 0.29 ± 0.03 s1

for C448D LodA are similar to that of WT LodA of 0.34 ± 0.01 s-1. Previous studies of

LodA have indicated that an active site base is needed to deprotonate the lysine-CTQ
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adduct during catalysis12, 132. As the Cys448 mutations do not significantly decrease kcat,
this residue does not appear to function as an active-site base or play any direct role in
the catalytic reaction steps. However, the Km values for both substrates were increased.
The Km for O2 of 544 ± 94 µM for C448A LodA is about 3-fold greater than that for WT
LodA. For C448D LodA the Km of 386 ± 70 µM is about 2-fold greater. The Km for lysine
of 48 ± 4 µM for C448A LodA is 12-fold greater than that for WT LodA and for C448D
LodA the Km of 142 ± 33 s-1 is 36-fold greater. These data suggest an important role for
Cys448 in lysine binding, or more specifically, facilitating the formation of the lysine-CTQ
adduct.
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Figure 14 Effects of the C448A and C448D mutations on the steady-state activity of LodA.
A. Assays were performed in the presence of a fixed concentration of 1150 O 2. B. Assays
were performed in the presence of a fixed concentration of 1 mM lysine. The symbols
represent WT LodA (▲), C448A LodA (■) and C448D LodA (●). The lines are fits of each
data set to eq 1.
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Effects of Tyr211 mutations
Tyrosine 211 is situated on a mobile loop in proximity to the active site of LodA
(discussed earlier). Tyr211 was mutated to Ala, Glu and Phe. In each case, the amount
of protein expressed and isolated was similar to that of WT LodA. However, only the
Y211F LodA exhibited activity. Interestingly the A400/A280 for the purified Y211A LodA and
Y211E LodA were each greater than that of WT LodA and equal to that of C448D LodA
which is the highest value observed in this study. This indicates that the lack of enzymatic
activity of Y211A and Y211E LodA is not due to lack of CTQ biosynthesis which was not
compromised, but apparently optimized by these mutations. In contrast to those
mutations, Y211F LodA exhibited an A400/A280 less than that of WT LodA suggesting that
the biosynthesis of CTQ is a bit less efficient in this variant. However, Y211F LodA was
active (Figure 15, Table 2). The kcat value of 0.19 ± 0.02 s-1 for Y211F is similar to that of
WT LodA of 0.34 ± 0.01 s-1, particularly when one takes into consideration the lower
A400/A280 for Y211F LodA. The Km for lysine is 129 ± 22 µM which is 30-fold greater than
for WT LodA. The Km of O2 is 522 ± 162 µM which is 2.7-fold greater than for WT LodA.
These results highlight the importance of an aromatic residue at position 211 for substrate
binding. While Y211F LodA has a near normal kcat, the affinity for each substrate is
significantly compromised. Y211A and Y211E LodA are completely inactive, despite the
presence of CTQ, suggesting that binding of substrates is further compromised in these
variants to the extent that activity is undetectable.
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FigureFigure
15 Effects
of the Y211A, K530R and K530A mutations on the steady-state activity
of LodA.

A. Assays were performed in the presence of a fixed concentration of 1150 O 2. B. Assays
were performed in the presence of a fixed concentration of 1 mM lysine. The symbols
represent WT LodA (▲), K530R (▼), K530A LodA (■) and Y211F LodA (●).The lines are
fits of each data set to eq 1.
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Effects of Lys530 mutations
Inspection of the one crystal structure in which Tyr211 is visible (PDB 3WEV)
reveals that it forms a hydrogen bond with Lys530 (Figure 11). As such, this residue was
mutated to Ala and Arg. The protein was expressed and isolated at levels comparable to
WT LodA. However, the A400/A280 was significantly decreased indicating that the presence
or absence of Lys530 does affect the extent of CTQ biosynthesis. While this residue is
not that close to CTQ, it is situated on the outer side of the active site and hence could
be involved in CTQ biosynthesis by a direct or indirect involvement with the modifying
enzyme LodB.
Interestingly, the mutations of Lys530 increased kcat (Table 2). For the reaction
catalyzed by K530A LodA the kcat is 1.2 ± 0.1 s-1 which is around 3.5-fold greater than for
WT LodA and that for K530R is 0.68 ± 0.04 s-1 which is double that of WT LodA.
Considering the lower A400/A280 for K530A and K530R LodA, the true kcat may be even
greater if one considers the lower level of CTQ that is present. While the kcat has been
significantly enhanced by these mutations, the affinity for each substrate was greatly
decreased. For K530A, the Km value for lysine is 52 ± 5 µM and that for O2 is 1043 ± 102
µM. For K530R, the Km value for lysine is 112.5 ± 12.9 µM and that for O2 is 706.1 ± 94.8
µM. While the affinity for O2 is significantly decreased, because of the increase in kcat, the
kcat/Km (O2) values for K530 and K530R LodA of 1150 s -1M-1 and 960 s-1M-1 and not that
much lower than the value for WT LodA of 1710 s-1M-1.
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Conservation of Cys448, Tyr211 and Lys530 in sequences of proteins encoded by
LodA-like genes
Analysis of the Integrated Microbial Genomes database of genome sequences
identified 168 genes from 144 different bacterial genomes that encoded LodA-like
proteins125. LodA from M. mediterranea was classified as a member of Group IA LodAlike proteins. Alignment of the sequences of the 20 members of the Group IA LodA-like
proteins reveals that the residues which were mutated in this study are highly conserved
in these sequences. Alignments of the regions of the sequence in which each of these
three residues reside revealed that Cys448 (Table 3) and Lys530 (Table 4) are each
conserved in each sequence. Tyr211 is conserved in 15 sequences and the other five
have a Phe in this position (Table 5).
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Table 3 Alignment of proteins in group IA.
Around Cys448 in LodA, Blue, consensus 100%; Red, >90%; H, hydrophobic residue; 1,
N or S
*, IMG gene identification
Locus tag

Organism

Marme_2662 LodA

LodA
Marinomonas
mediterranea MMB-1
Marinomonas sp. MWYL1
Marinomonas sp GOBB3-320
Pseudoalteromonas
tunicata
D2
Flavobacterium subsaxonicum
DSM 21790
Pseudoalteromonas
citrea
NCIMB 1889
Rheinheimera sp. A13L
Aquimarina
muelleri
DSM
19832
Pseudoalteromonas
luteoviolacea 2ta16
Pseudoalteromonas
flavipulchra 2ta6
Pseudoalteromonas
flavipulchra JG1
Pseudoalteromonas piscicida
JCM 20779
Pseudoalteromonas piscicida
ATCC 15057
Geitlerinema sp. PCC 7105
Nitrosococcus halophilus Nc4
Duganella zoogloeoides ATCC
25935
Nitrolancetus hollandicus Lb
Pseudomonas
resinovorans
DSM 21078
Pseudomonas
viriddaflava
CC1582
Pseudomonas
viridaflava
TA043

Mmwyl1_3721
M320_pool_00037300
PTD2_20217
G509DRAFT_1169
PCIT_22609
Rhein_1334
H527DRAFT_03370
PL2TA16_00557
PflaDRAFT_00041100
UY7DRAFT_03653
PPIS_19511
G366DRAFT_02721
Gei7105DRAFT_0285
Nhal_1391
F460DRAFT_04769
2520384729*
G559DRAFT_00896
CC1582_00022990
TA043_00024900

Sequence of residues 430-463 in LodA
xhxxxDxxxhGNCVGxPxCPGIEVTWSxx1xxhY
PVSDMDTASIGNCVGLPMCPGIEMTWSLQNPVIY
PVNEMDAASIGNCVGLPMCPGIEVTWSLQNSKLY
YVNEMDAASIGNCVGLPMCPGIEVTWSLQNSKLY
AVHPLDKASIGNCVGLPMCPGIEVTWSLQNPNLY
PVSLDDTASVGNCVGLPMCPGIEVTWSMQNPAVY
PVDPLDQGSVGNCVGLPMCPGIEVTWSLQNPKVY
PVNPLDQGSVGNCVGLPMCPGIEVTWSMQNPAVY
AISEIDMASVGNCVGLPMCPGIEVTWSLQNENIY
GVFYADQSSVGNCVGLPMCPGIEVTWSMQNPAVY
GVFYADQGSVGNCVGLPMCPGIEVTWSLQNPAVY
GVFYADQGSVGNCVGLPMCPGIEVTWSLQNPAVY
GVFYADQGSVGNCVGLPMCPGIEVTWSLQNPAVY
GVFYADQGSVGNCVGLPMCPGIEVTWSLQNPAVY
GVDDRDRASVGNVVGLPQCPGIEVTWTTQNPIVY
PLCSATSAAMGNCVGLPMCPGIEVTWSMQNPAIY
GIAALDRAAIGNCVGEPMCPGIEVTWSVRNPVIY
GIHPLDRVDIGNCVGDPMCPGIEVTWSVRNPAIY
GVTALDRASVGNCVGGPLCPGIEVTWSLYSPELY
NVTDLDRASVGNCVGGPFCPGIEVTWSLYSKALY
NVTDLDRASVGNCVGGPFCPGIEVTWSLYSKALY
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Table 4 Alignment of proteins in group IA.
Around Lys530 in LodA, Blue, consensus 100%; Red, >90%; h: hydrophobic residue; 1,
E or Q; 2, I or V; 3, S or T; 4, I or L
*, IMG gene identification.
Locus tag

Organism

Marme_2662

LodA Marinomonas mediterranea MMB-1

Mmwyl1_372
1
M320_pool_
00037300
PTD2_20217

Marinomonas sp. MWYL1

G509DRAFT
_1169
PCIT_22609

Flavobacterium subsaxonicum DSM 21790

Rhein_1334

Rheinheimera sp. A13L

H527DRAFT
_03370
PL2TA16_00
557
PflaDRAFT_
00041100
UY7DRAFT_
03653
PPIS_19511

Aquimarina muelleri DSM 19832

G366DRAFT
_02721
Gei7105DRA
FT_0285
Nhal_1391

Pseudoalteromonas piscicida ATCC 15057

F460DRAFT
_04769
2520384729*

Duganella zoogloeoides ATCC 25935

G559DRAFT
_00896
CC1582_000
22990
TA043_0002
4900

Pseudomonas resinovorans DSM 21078

Sequence of residues 494-590 in LodA
xGC1PGDLTKRMAxPWQADFFxC32Qx2NFxxPxhN
K
PxxPxYYxYWWPPQSPWDV4
TGCEPGDLTKRMACPWQADFFNCTIQTVNFSEPSV
NK (x)40 PLPPAYYSYWWPPQSPWDVL
VGCEPGDLTKRMACPWQADFFNCTVQVVNFSEPKV
NK (x)40 PLPPAYYSYWWPPQSPWDVL
GGCEPGDLTKRMACPWQADFFNCTVQVVNFSEPK
VNK (x)40 PLPPAYYSYWWPPQSPWDVL
GGCQPGDLTKRMACPWQADFFQCTVQPVNFTEPLI
NK (x)74 PITPTYYSYWWPPQSPWDVL
GGCEPGDLTKRMACPWQADFFECTIQTINFSDPAVN
K (x)08 PLPPTYYSYWWPPQSPWDVI
GGCEPGDLTKRMACPWQADFFQCTIQNINFTNPAK
NK (x)04 PLPPTYYSYWWPPQSPWDVL
GGCQPGDLTKRMACPWQADFFQCTVQPVNFTVPE
VNK (x)04 PLPPTYYAYWWPPQSPWDVL
GGCEPGDLTKRMACPWQADFFQCTIQYINFSDPEIN
K (x)34 PLPPSYYTYWWPPQSPWDVL
GGCQPGDLTKRMACPWQADFFNCTIQNVNFTDPTV
NK (x)12 PLAPTYYSYWWPPQSPWDVL
GGCQPGDLTKRMACPWQADFFNCTIQNVNFTEPTV
NK (x)12 PAAPTYYSYWWPPQSPWDVL
GGCQPGDLTKRMACPWQADFFNCTIQNVNFTEPTV
NK (x)12 PAAPTYYSYWWPPQSPWDVL
GGCQPGDLTKRMACPWQADFFNCTIQNVNFTEPTV
NK (x)12 PAAPTYYSYWWPPQSPWDVL
GGCQPGDLTKRMACPWQADFFNCTIQNVNFTEPTV
NK (x)12 PAAPTYYSYWWPPQSPWDVL
GGCEPGDLTKRMAIPWQADFFNCSIQFVNFTDPNV
NK (x)09 PKPPTYYSYWWPPQAPWNVL
GGCEPGDLTKRMAIPWQADFFNCTIQYVNFTDPDIN
K (x)04 PLPPSYYAYWWPPQAPWDVL
SGCEPGDLTKRMAIPWQADFYDCSVQMINFDNPDL
VK (x)06 PVPPTYYAYWWPPQSPWNVI
GGCEPGDLTKRMAIPWQADFFACSVQYINFTDPNV
NK (x)04 PKPPTFFAYWWPPQSPMHVI
QGCEPGDLTKRMAIPWQADFFQCTVQYVNFTDPEV
NK (x)04 PKAPSYYAYWWPPQSPWNVL
QGCEPGDLTKRMATPWQSDFFQCTVQYINFSDSDA
NK (x)04 PKPPTYYAYWWPPQSPWNVI
QGCEPGDLTKRMATPWQSDFFQCTVQYINFSDNDA
NK (x)04 PKPPTYYAYWWPPQSPWNVI

Marinomonas sp GOBB3-320
Pseudoalteromonas tunicata D2

Pseudoalteromonas citrea NCIMB 1889

Pseudoalteromonas luteoviolacea 2ta16
Pseudoalteromonas flavipulchra 2ta6
Pseudoalteromonas flavipulchra JG1
Pseudoalteromonas piscicida JCM 20779

Geitlerinema sp. PCC 7105
Nitrosococcus halophilus Nc4

Nitrolancetus hollandicus Lb

Pseudomonas viriddaflava CC1582
Pseudomonas viridaflava TA043
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Table 5 Alignment of proteins in group IA.
Around Tyr211 in LodA, Blue, consensus 100%; Red, >90%; h: hydrophobic residue; 1,
G or S; 2, Y or F; 3, G or A; 4, S or A
*, IMG gene identification.
Locus tag

Organism

Marme_2662

LodA Marinomonas
mediterranea MMB1
Marinomonas
sp.
MWYL1
Marinomonas
sp
GOBB3-320
Pseudoalteromonas
tunicata D2
Flavobacterium
subsaxonicum DSM
21790
Pseudoalteromonas
citrea NCIMB 1889
Rheinheimera sp.
A13L
Aquimarina muelleri
DSM 19832
Pseudoalteromonas
luteoviolacea 2ta16
Pseudoalteromonas
flavipulchra 2ta6
Pseudoalteromonas
flavipulchra JG1
Pseudoalteromonas
piscicida
JCM
20779
Pseudoalteromonas
piscicida
ATCC
15057
Geitlerinema
sp.
PCC 7105
Nitrosococcus
halophilus Nc4
Duganella
zoogloeoides ATCC
25935
Nitrolancetus
hollandicus Lb
Pseudomonas
resinovorans DSM
21078
Pseudomonas
viriddaflava
CC1582
Pseudomonas
viridaflava TA043

Mmwyl1_3721
M320_pool_00037300
PTD2_20217
G509DRAFT_1169

PCIT_22609
Rhein_1334
H527DRAFT_03370
PL2TA16_00557
PflaDRAFT_00041100
UY7DRAFT_03653
PPIS_19511

G366DRAFT_02721

Gei7105DRAFT_0285
Nhal_1391
F460DRAFT_04769

2520384729*
G559DRAFT_00896

CC1582_00022990

TA043_00024900

Sequence of residues 182-230 in LodA
LGxhxTDxxGRLhVhGGxGxAGGxxxhx123GxxxWxDDx4DGxVxC
xh
LGTLRTDSQGRLIVLGGYGFAGGNTDLSGYGGGDDWYDDISDGS
VTCVV
LGTLLTDDKGRLIVLGGYGRAGGNTDLEGYGGGDEWFDDISDGP
VTCVV
LGTLRTDNKGRLIVLGGYGRAGGNTDLEGYGGGDEWFDDISDGP
VTCVV
LGTLKTDNKGRLIVFGGYGHAGGDEALTSYGGSDTWHDDTADGP
VYCEV
LGNLLTDASGRLVVLGGYGNAGGNEPLTSYGGSSTWHDDISDGP
VYCTV
LGDLKTDNEGRLIVLGGYGHAGGDKPLVSYGGSDTWHDDIADGP
VYCTV
LGDLLTDDLGRLIVLGGYGNAGGDEPLTSYGGSNTWHDDISDGPV
YCTV
LGDLLTDDEGRLIVLGGYGHAGGNEPLTSYGGSNTWHDDISDGPV
YCTI
LGNILTDNEGRLVVIGGFGNAGGNEPLESYGGADTWHDDIADGTV
YCTV
LGDILTDNEGRLVVLGGKGNAGGNLPLESYGGADTWHDDIADGTV
YCTV
LGDILTDNEGRLVVLGGKGNAGGNQPLESYGGADTWHDDIADGT
VYCTV
LGDILTDNEGRLVVLGGKGNAGGNQPLESYGGADTWHDDIADGT
VYCTV
LGDILTDNEGRLVVLGGKGNAGGNQPLESYGGADTWHDDIADGT
VYCTV
LGTLKTDSSGRLLVLGGFGKSGGDLPLSSYGGADTWYDDISDGSV
TCTI
LGTIKTDREGRLLVLGAYGRAGGDEPITSYGGADTWYDDIADGPV
ECTV
LGEMRTDSAGNLLVIGAYGRAGGIDPITGFGGGDTWNDDIADGPV
TATV
LGDLLTDADGRLLVLGGFGKAGGSEPITSFAGADTWHDDVSDGP
VSCKL
LGEMRTDQQGRLLVLGGYGHAGGNQSITSFAGADGWHDDISDGP
VTCTL
LGGVLTDNKGRLLVLGGYGHAGGDQSITSFAGADTWHDDTSDGP
VTCTL
LGGVLTDKKGRLLVLGGYGHAGGDQSITSFAGADTWHDDTSDGP
VTCTL
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Discussion
Site-directed mutagenesis of residues in the substrate channel of LodA have
demonstrated that Cys448, Tyr211 and Lys530 play multiple roles in regulating Km values
of substrates, kcat and the extent of biosynthesis of the protein-derived CTQ cofactor. It
may seem intuitively odd that the WT enzyme would have less CTQ formed than some
LodA variants. However, the fact that certain mutations either decrease or increase the
efficiency of LodB-dependent CTQ biosynthesis is significant. This means that, in addition
to furthering our understanding of the functional roles of these residues in the activity of
LodA, these results highlight the point that different evolutionary factors must be
considered for enzymes which possess protein-derived cofactors. Residues present in
the active site that may be optimal for catalytic efficiency may not be the best to participate
in CTQ biosynthesis, and vice versa. While CTQ biosynthesis is catalyzed by another
enzyme, the residues surrounding the nascent CTQ may play important roles in properly
positioning the Cys and Trp residues for modification or substrate oxygen for insertion, or
both. In this regard, it has been shown that the first modification in the biosynthesis of
CTQ takes place auto-catalytically in the absence of LodB, and that some LodA residues
are involved in that process128.
The residue which corresponds in structure to Cys448 in two other
quinoproteins, the CTQ-containing QHNDH101 and the TTQ-containing MADH144, is a
structurally conserved Asp residue. Mutation of this corresponding Asp in MADH affected
the efficiency of MauG-dependent TTQ biosynthesis but had no effect on the catalytic
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activity of the population of the isolated MADH with fully formed TTQ 95. Consistent with
the results of the MADH study, it can be concluded that the residue at this position,
Cys448 in LodA, is not the active-site base that is involved in deprotonation of the lysineCTQ adduct during catalysis as the C448A mutation has no significant effect on kcat.
However, in contrast to the results of the MADH, mutation of Cys448 in LodA to Ala did
not result in decreased levels of CTQ biosynthesis. Furthermore, the C448D LodA
mutation appears to have enhanced the efficiency of CTQ biosynthesis. This suggests
that the native LodA is a mixed population in which some of the protein has incompletely
synthesized CTQ and is inactive. Together with the previous study that showed a role for
the corresponding Asp in TTQ biosynthesis in MADH, it appears that an Asp residue in
this position is preferred for tryptophylquinone cofactor biosynthesis. However, for LodA
the presence of Asp at this position is not optimal for catalysis. In particular, this mutation
increases the Km for lysine 35-fold. Thus, the sub-optimal role in CTQ biosynthesis of
Cys448 is more than compensated for by the greater catalytic efficiency of the enzyme.
Mutation of Tyr211 and its H-bonding partner Lys530 had significant effects on
both kcat and Km values. As discussed earlier, Tyr211 is present on a mobile loop and it
is possible that the H-bond to Lys530 could anchor it in place at certain times during the
catalytic cycle. The aromatic character of residue 211 seems critical for activity since the
Y211F LodA retains function, whereas Y211A LodA and Y211E LodA are inactive. The
K530A and K530R mutations significantly increased the Km values for the substrates,
particularly O2. For lysine is increased 13- and 29-fold, respectively while for O2 it
increased 5- and 3.5-fold respectively. Since the loop containing Tyr211 was not
74

observed in the structure of the lysine-CTQ adduct of LodA [8] it may not be important in
stabilizing that intermediate. It is possible that Tyr211 in concert with Lys530 could aid in
O2 binding, or retention of O2 in the active site to poise it for action. This would be
consistent with the hydrophobic nature of residue 211 being important. Interestingly, the
K530A mutation significantly increased kcat. Since the rate-limiting step for the overall
reaction catalyzed by LodA is not known, it is difficult to interpret this effect. Given the
position of Lys530 in the active site, and the fact that mutations to Ala and Arg each
enhance rather than eliminate activity, these results suggest that Lys530 is not playing a
direct role in acid-base chemistry or nucleophilic attack during catalysis. However, it is
possible that that it could control the rate of binding of one or both of the substrates, or
release of one or more of the products. If the hydrogen-bond between Lys530 and Tyr211
stabilizes the positions of these residues such that they impede the entry into or exit from
the active site, then the removal of this blockage of the active site channel caused by the
K530A mutation could possibly accelerate a rate-limiting product release step which could
account for the increase in kcat. This would also be consistent with the large increases in
the Km values that are caused by mutation of Lys530. In this sense the mobile loop which
can be anchored by a hydrogen-bond between Tyr211 and Lys530 could act as a switch
that regulates entry of substrates and exit of products to and from the active site.
A couple of points require consideration regarding the kinetic analysis of the LodA
variants. As stated earlier, it was not possible to perform a detailed steady-state analysis
in which both substrates were varied over an appropriate range of concentrations of each
substrate. As such, it is an assumption that each variant obeys a ping-pong mechanism
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as does WT LodA. For example, with some flavoprotein oxidases it may be possible for
reoxidation of the cofactor to precede or follow the release of the oxidized product.
However, in the case of LodA, the substrate forms a covalent adduct with CTQ (Figure 2)
and it is difficult to imagine how these mutations could alter the kinetic mechanism to
allow O2 to reoxidize the cofactor prior to release of the aldehyde product. It should also
be noted that the mutations in this study involve residues with ionizable groups. It was
previously shown12 that kcat for LodA exhibits a bell-shaped pH profile with a maximum at
pH 7.5, implicating the involvement of at least two ionizable groups, and that the Km for
lysine also varied in this range. As such, it was not possible to compare kinetic parameters
in a pH-independent region.
These results reflect the different evolutionary factors that must be considered
for enzymes which possess protein-derived cofactors. Since the catalytic cofactor must
be generated by posttranslational modifications, this suggests that the protein must have
originally evolved for some other purpose. The modifying enzyme likely also originally
evolved for a different purpose. The residues in the active site could not have evolved to
optimize function as a lysine oxidase until after the evolution of the LodA that led to its
specific interaction with the modifying enzyme LodB and the ability to catalyze CTQ
biosynthesis. This is well-described by the observation that some Y211A and Y211E
mutations maximize levels of CTQ biosynthesis but are inactive in catalysis. Also
consistent with this argument is the observation that Lys530 mutations lead to decreased
CTQ biosynthesis but increased kcat. The fact that each of the mutations in this study
increased Km values for lysine and O2 further indicate that the combination of residues
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throughout the active site channel together participate in the specificity and catalytic
efficiency of the enzyme.
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CHAPTER 5: GLYCINE OXIDASE (GOXA)

Introduction

LodA is a unique protein in itself as it is the first among the group of L-amino
acid oxidases to be a quinoprotein instead of a flavoprotein. Upon further investigation it
was discovered though that there was a complete new reservoir of LodA-like proteins
containing CTQ cofactors. The only other CTQ containing protein that has been studied
so far has been the QHNDH. But due to the complexity in its structure complete
characterization was not possible. Of late a new protein from the same Marinomonas
mediterranea was found to show glycine oxidase activity and has been referred to as
GoxA. It is similar to LodA in a lot of aspects. Both have been found to contain
tryptophylquinone (CTQ) cofactor instead of being flavoproteins like the other Laminoacid oxidases. The Cys and the Trp that are supposedly involved in the CTQ
formation have been found to be conserved. Both the lodA and the goxA genes have a
second gene lodB and goxB respectively present downstream which encodes proteins
that are necessary for the mature CTQ generation. LodA and GoxA have been found to
show 22.8% identity and 34.6% similarity (distribution in microbial genomes). A crystal
structure of LodA has been reported but one for GoxA hasn’t been reported yet. Figure
16 shows an overlay of the homology model of GoxA with the crystal structure model of
LodA. The major differences lie in the type of amino acid that they use as substrates.
LodA carries out the oxidative deamination of L-lysine whereas the GoxA catalyzes the
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reaction for glycine. Upon phylogenetic and sequence analysis LodA and GoxA were put
in 2 different groups. Group IA included the LodA and similar proteins and group II had
the GoxA and similar proteins. Most of the proteins in Group II contain a twin arginine
sequence. This is absent in the Group I LodA-like proteins indicating that there could be
difference in the final translocation of the proteins which would thus have an effect on the
overall function of each of these enzymes in the marine bacterium. A third protein has
also been found from the same bacterium and has been thought to be LodA-like, but its
function has not yet been discovered. This brings about an interesting observation.
Marinomonas mediterranea encodes both LodA and GoxA. But based on the sequence
and phylogenetic analysis they have been placed in different groups. This could be based
on different enzymatic actions. Hence in order to study the diversity in the group of these
unusual tryptophylquinone cofactor containing oxidases, GoxA was chosen as the second
protein to study. By characterization of GoxA a better understanding could be obtained
about the similarities and differences in the structure, function, mechanism of the reaction
catalyzed.

79

GoxA

LodA

Figure 16 Overlay of the homology model of GoxA with the model for the established
crystal structure of LodA.
Red – LodA, Blue – GoxA.
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CHAPTER 6: INTERACTION OF GOXA WITH ITS MODIFYING ENZYMES AND ITS
SUBUNIT ASSEMBLY ARE DEPENDENT ON THE EXTENT OF CYSTEINE
TRYPTOPHYLQUINONE BIOSYNTHESIS
Biochemistry, 2016, 55 (16), pp 2305–2308
Introduction
Quinoproteins

may

contain

exogenous

quinone

cofactors

such

as

pyrroloquinoline quinone134 or protein-derived quinone134 cofactors that are formed by
irreversible posttranslational modification of amino acid residues, most notably Tyr and
Trp (Figure 17)6. Tyrosine-derived cofactors include trihydroxyphenylalanine (Topa)
quinone (TPQ)57 which is found in several copper-containing amine oxidases53 and lysyl
tyrosylquinone (LTQ) which is found in lysyl oxidase135. Tryptophan-derived cofactors
include tryptophan tryptophylquinone (TTQ) which is found in amine dehydrogenases and
cysteine tryptophylquinone (CTQ) which was been found in quinohemoprotein amine
dehydrogenase (QHNDH)71, in an ε-lysine-epsilon oxidase (LodA)101 and in a glycine
oxidase (GoxA)8.
The mechanisms of the biosynthesis of the protein-derived quinone cofactors
differ from cofactor to cofactor14. For the Tyr-derived cofactors it is a self-processing event
which is dependent on the presence of copper and O 2. The copper facilitates oxygen
insertion in the Tyr side chain and subsequently remains in the active site and assists in
catalysis146,

147.

The biosynthesis of TTQ in methylamine dehydrogenase (MADH)

includes posttranslational modifications that are catalyzed by a diheme enzyme called
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Figure 17 Protein-derived quinone cofactors formed by posttranslational modification.
CTQ is cysteine tryptophylquinone cofactor. TTQ is tryptophan tryptophylquinone
cofactor. TPQ is 2,4,5-trihydroxyphenylalanine quinone or Topaquinone. LTQ is lysine
tyrosylquinone.
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MauG72. The mechanism of the biosynthesis of CTQ in QHNDH has yet to be fully
characterized, but it does require one or more other gene products8. In the case of LodA
and GoxA it has been shown that flavoproteins are required for the biosynthesis of CTQ,
although no mechanistic studies have been thus far reported. The posttranslational
modifications required for CTQ biosynthesis are the incorporation of two oxygen atoms
into the side-chain of a specific Trp residue and covalent cross-link formation between
that residue and a Cys residue (Figure 17). LodA and GoxA were isolated from the marine
bacteria, Marinomonas mediterranea71, 101. The gene clusters which encode LodA and
GoxA each contain only one other gene, lodB and goxB89. Each of these genes is
predicted to encode a putative flavoprotein. Expression of either active LodA or GoxA
with the mature CTQ cofactor requires that lodA and goxA each be co-expressed with
lodB and goxB, respectively124. Expression of either active lodA or goxA in the absence
of lodB or goxB, respectively, leads to the production of inactive forms of the proteins that
lack CTQ. These precursor proteins have been termed preLodA and preGoxA11.
This study reports the isolation and characterization of a complex of precursor
GoxA and GoxB. It is shown that a flavin is indeed present in this complex with the
putative flavoprotein, GoxB, and that mature CTQ is not present in the precursor form of
GoxA. An active GoxA with mature, CTQ which is not in complex with GoxB, is also
isolated from the same prep. Evidence is presented that the affinity between GoxA and
GoxB is dependent upon the extent of CTQ biosynthesis. Furthermore, it is shown that
the oligomerization state of GoxA is dependent on the extent of CTQ biosynthesis. These
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results are compared and contrasted with the features of the biosynthesis of TTQ and
TPQ in their respective enzymes.
Materials and methods
GoxA and GoxB were expressed in E. coli Rosetta cells. The cells were
transformed with the pET15GoxAB plasmid which contained goxA, to which a
hexahistidine tag had been added and goxB downstream of goxA. The cells were grown
in LB media which also contained ampicillin and chloramphenicol. Cells were grown at
30˚C to an OD of 0.6. At that point 1 mM IPTG was added and after four hours cells were
harvested. The harvested cells were sonicated in 50 mM potassium phosphate, pH7.5,
and centrifuged. The supernatant was passed through a Ni-NTA affinity column. The
column was washed using a gradient of imidazole in the same buffer. Protein eluted over
a range of 30-150 mM imidazole. The eluted protein was dialyzed and again applied to
the affinity column and the process was repeated using a narrower imidazole gradient to
improve purity and to better separate the two fractions. As discussed in the results, two
fractions were identified, one containing both GoxA and GoxB which eluted at lower
imidazole concentration and one which contained GoxA alone that eluted at higher
imidazole concentration.
Glycine oxidase activity was determined using a coupled enzyme assay which
had been previously described101. The assay was performed under aerobic conditions at
30˚C. In addition to the glycine substrate the assay mixture contained 20 U/ml glutamate
dehydrogenase 5 mM 2-oxoglutarate and 0.25 mM NADH. The reaction was initiated by
addition of 2 mM glycine. The ammonia generated by the oxidative deamination of glycine
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(eq 1) was used as a co-substrate by glutamate dehydrogenase (eq 2) leading to the
oxidation of NADH which accompanied by a decrease in absorbance at 340 nm (ε 340 of
NADH is 6220 M-1cm-1).
glycine + O2 + H2O → glyoxylate + NH3 + H2O2

(6.1)

2-oxoglutarate + NH3 + NADH → glutamate + H2O + NAD+

(6.2)

SDS-PAGE was performed by standard methods 7.5% gels. Gels were stained
for protein with EZ protein gel staining solution. In order to perform the quinoprotein stain
for detection of a covalent quinone proteins, without staining for protein, electrophoretic
transfer of the proteins to a nitrocellulose membrane (0. 2µm pure nitrocellulose
membrane, BioRad) was performed. This was done at 120 V for 1h at low temperature to
prevent overheating. To stain for the presence of quinoproteins11, the nitrocellulose
membrane was incubated for 45 min in the dark in a solution of 2 M potassium glycinate,
pH 10, containing 0.24 mM Nitro Blue Tetrazolium71. The quinoproteins will stain. The
nitrocellulose membrane was then washed and stored in 0.1 M sodium borate, pH 10.0
until dried.
Size exclusion chromatography (SEC) was performed using a HiLoad 16/600
Superdex 200 column (GE Healthcare). The buffer used for chromatography was 50 mM
potassium phosphate buffer, pH 7.5, containing 150 mM NaCl. The flow rate was 0.6
mL/min. Glutamate dehydrogenase (332 kDa), MADH (124 kDa), MauG (42 kDa) and
amicyanin (11.5 kDa) were used as standards. Blue dextran was used to determine the
void volume. Gaussian fits of the chromatogram (Prism Graph Pad) were used to resolve
overlapping peaks in the chromatogram and integrate the areas under the peaks.
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Results
During purification of the His-tagged recombinant GoxA, two protein fractions
eluted from the Ni-NTA resin affinity column, one at approximately 60 mM imidazole and
the other at approximately 100 mM imidazole. When assayed for glycine oxidase activity
the first fraction exhibited no activity, whereas the second fraction was active and
exhibited a kcat of 14.90 ± 0.02 s-1 under aerobic conditions (252µM O2) with 2 mM glycine
concentration and 30˚C.. Each of the fractions exhibited a different visible absorption
spectrum. That fraction that was active exhibited spectral features in the 350–420 nm
range that are consistent with the presence of CTQ with peaks (Figure 18A). Similar
visible absorbance spectra have been reported for LodA148 and the ε subunit of QHNDH13
and a synthetic CTQ model compound105. In contrast, the inactive fraction exhibited as
absorbance spectrum with features characteristic of a flavin. (Figure 18B). This suggest
that the fraction contained GoxB, although that protein did not have a His-tag. From this
spectrum it could not be concluded whether or not CTQ was also present as the
absorbance of the flavin would mask the CTQ spectrum.
The two fractions were analyzed by SDS-PAGE (Figure 19A). The inactive fraction
contained two species. The larger band migrated as expected for GoxA which has a
predicted mass from the gene (Marme_1655) of 76284.8 Da. The other migrated as would
be expected for GoxB which has a predicted mass from the gene (Marme_1654) of
41856.3 Da. That active fraction contained only one major species which migrated as
expected for GoxA. Analysis by mass spectrometry confirmed that the second species
was exactly the molecular weight of the untagged GoxB. Unfortunately the intact GoxA
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Figure 18 Visible absorption spectra of the two protein fractions that eluted from the NiNTA affinity column.
A. Absorption spectrum of the active fraction which exhibits a spectrum characteristic of
CTQ. B. Absorption spectrum of the inactive fraction exhibits a spectrum characteristic of
flavin.
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species did not fly in the mass spectrometer and so it was not possible to determine from
the mass whether or not CTQ was present in the GoxA in the inactive fraction which coeluted with GoxB. It was not possible to separate the two proteins in the inactive fraction
by other chromatographic techniques. The sample was subjected to anion exchange
(DEAE) chromatography, hydrophobic interaction chromatography using butyl sepharose
and size exclusion chromatography. In each case the proteins co-eluted indicating that
the two proteins interact with each other to form a tight complex.
Two possible reasons for the lack of activity in the fraction containing the GoxAGoxB complex are that either the presence of the second protein interferes with the
reaction or the GoxA is actually a precursor lacking the mature CTQ cofactor. As the
presence or absence of CTQ could not be confirmed by the absorbance spectrum or
mass spectrometry analysis, an alternative was used to determine whether CTQ was
present. The proteins were subjected to SDS-PAGE followed by electroblot to a
nitrocellulose membrane which was subjected to a staining protocol that is specific for
covalent quinoproteins148 (Figure 19B). The active GoxA that eluted by itself stained
positive. The GoxA which co-eluted with GoxB did not stain indicating that it does not
have the mature CTQ cofactor. Thus, it is actually the precursor GoxA. Additional proteins
were included on the gel as positive and negative controls. Two proteins were included
in which the presence of the quinone cofactor has been verified in crystal structures.
MADH contains two subunits with TTQ present in the smaller subunit144. The smaller
subunit stained positive and the larger one did not. LodA, which contains CTQ132 also
stained positive.
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Figure 19 SDS-PAGE and quinoprotein staining of protein fractions.
Top. SDS gel stained for protein. Bottom. Western blot of a gel identical to that in A which
was stained for quinoproteins. The lane labeled GoxA is the active fraction gel stained
for protein. The lane labeled GoxAB is the inactive fraction. The TTQ-bearing MADH and
CTQ-bearing LodA were used as controls.

89

The GoxB present in complex with the precursor form of GoxA did not stain. Comparable
amounts of GoxA, MADH, LodA, and the precursor GoxA-GoxB complex were loaded on
the gel. GoxA and LodA did not transfer to the nitrocellulose as efficiently as the other
proteins. For that reason the gel in Figure 19A, which is identical to the one which was
used in the electroblot transfer to a nitrocellulose membrane was intentionally overloaded
to ensure that a negative result was not because of insufficient transfer of proteins. For
further confirmation a dot blot was performed in which the protein sample was spotted
directly on the nitrocellulose membrane, dried and then subjected to the staining
procedure. Again the active protein stained positive and the inactive did not, indicating
that whereas the active GoxA has mature CTQ the GoxA in complex with GoxB does not
(Figure 20)
The inactive and active fractions were also characterized by size exclusion
chromatography. The active GoxA with CTQ eluted from the column primarily as a dimer
(Figure 21A). Two peaks were observed. The relative mass of the major peak (84%) was
approximately 140 kDa and that of the minor peak (16%) was approximately 76 kDa which
is the predicted molecular weight of the monomer. The inactive fraction containing
precursor GoxA and GoxB eluted 100% as a single peak with a relative mass of
approximately 120 kDa which is approximately the sum of the predicted molecular
weights of GoxA and GoxB (Figure 21B).
The implications of these results are profound.
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A

B

C

Figure 20 Dot Blot on nitrocellulose membrane.
A. 8µg of GoxA stained positive for quinoprotein stain. B. 8µg of LodA stained positive for
quinoprotein stain. C.8ug of precursor GoxA and GoxB complex which did not stain for
the quinoprotein indicating the absence of a mature CTQ.
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Figure 21 Size exclusion chromatography
The active fraction containg GoxA (A) and the inactive fraction containing precursor GoxA
and GoxB (B). The positions of elution and molecular weights of standards used to
calibrate the column are indicated.
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Together the results indicate that the GoxA precursor forms a tight complex with GoxB,
whereas GoxA with mature CTQ does not. Thus, complex formation between the two is
strongly dependent upon the extent of CTQ biosynthesis. Furthermore, the native dimeric
structure of active GoxA is not achieved until after CTQ formation and release of GoxB.
Thus, the oligomerization state of GoxA is also dependent upon the extent of CTQ
biosynthesis. The latter point is in stark contrast to what was observed for TTQ
biosynthesis in MADH by the diheme enzyme MauG. In that system it was shown that
preMADH existed as a heterotetramer and formed a complex with two molecules of
MauG, one associated with each halve of the heterotetramer88. Thus, in contrast to the
results obtained for GoxA, the assembly of MADH showed no dependence on the extent
of TTQ biosynthesis.

Discussion
The mechanisms of the biosynthesis of protein-derived cofactors are complex and
diverse.

The

most

common

protein

posttranslational

modifications,

such

as

phosphorylation and glycosylation, occur at the surface of the proteins enabling the
substrate residues to directly contact the modifying enzyme. In contrast, the amino acid
residues that undergo posttranslational modification reside within the protein. Some of
these modifications are self-processing events. As discussed earlier, an example of this
is the TPQ cofactor of copper-containing amine oxidases. In this case the host protein
binds copper which is used to activate oxygen for insertion into the side-chain of a specific
Tyr residue149 and then participates in catalysis142, 143.
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The

best

characterized

process

of

enzyme-catalyzed

posttranslational

modifications to form a quinone cofactor is the biosynthesis of the TTQ cofactor of MADH
by the diheme enzyme MauG. It was shown that the oxidation of the residues of the
precursor protein of MADH (preMADH) by a unique bis-FeIV high-valent state of the heme
did not occur by direct reaction. Instead it required long range electron transfer from the
substrate to the hemes through the protein by a hole-hopping mechanism of electron
transfer. It was possible to crystallize a catalytically competent complex of preMADH and
MauG. However the proteins did not form a stable complex in solution, as do precursor
GoxA and GoxB. Kinetic studies demonstrated that the affinity of MauG for preMADH was
approximately 10-fold greater than for MADH with mature TTQ, but the interactions were
transient. In the present study difference in affinity of GoxB for the GoxA precursor protein
is far greater than for the modified GoxA. In one case a complex forms which cannot be
separated and in the other complex formation is undetectable.
LodA which is also isolated from the same bacterium as GoxA also contains a CTQ
cofactor. The biosynthesis of the cofactor is dependent upon the flavoprotein LodB. In
contrast to what was observed with GoxA, no complex of preLodA or LodA with LodB was
ever observed during purification. In fact, the preparation of pure LodA was found to
contain preLodA as well which was clearly not in complex with LodB. Thus, while preLodA
and LodB must interact to achieve CTQ biosynthesis, the complex formation between the
two must be transient as was the case with preMADH and MauG, and different from what
was observed for precursor GoxA-GoxB complex. The observation is also consistent with
the previous observation that LodB and GoxB cannot substitute for each other and are
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specific for their respective LodA and GoxA precursor proteins. It seems that it may not
just be specificity but the mechanisms of action of LodB-dependent and GoxB-dependent
CTQ biosynthesis may have significant differences.
These results also demonstrate that CTQ formation in GoxA occurs prior to its
forming its native dimeric state. This is in stark contrast to what was observed in the
MADH-MauG system. This initial characterization of the tight complex formed by GoxA
precursor and GoxB is an important step towards for future studies to characterize the
details of the mechanism of CTQ formation by GoxB. As GoxB is a flavoprotein, this
mechanism will likely describe novel reactions the catalysis of which are unprecedented
for a flavin cofactor.
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CHAPTER 7: GLYCINE OXIDASE (GOXA) PREPS FOR OPTIMIZING YIELDS OF
THE PROTEIN
Introduction
GoxA was being expressed by transforming into the Rosetta cells, the pET15
plasmid vector containing the goxA and the goxB gene present on the same operon.
These preps resulted in the formation of a small amount of the 2 different fractions of
protein, the precursor GoxA-GoxB and the matured GoxA. In order to completely
characterize an enzyme, its kinetic properties needed to be studied. Since the yield from
these cultures were not satisfactory to carry out the studies, other constructs were made
to see if the expression could be optimized. Table 6 shows the different constructs that
were used to express more active GoxA. Different factors were considered for this.
1. Co-expression of the proteins from genes on different plasmids could improve the
yield.
2. The GoxA genes all had N-terminal His tags with a few extra amino acid coding
codons. His tags were engineered into the C-terminal end to ensure that the His
tag on the N-terminal side wasn’t affecting the overall expression of the protein.
Materials and methods
When 2 different plasmids were used with the goxA and the goxB gene
separately, co-transformation was done in order to express the proteins. The
pColADuetGoxA The Rosetta cells were grown and induced at 30˚C for 4hours. For the
pColADuetGoxA + pET11GoxB His tagged, BL21 cells were used and grown passed
through Ni-NTA columns for better separation.
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Table 6 Plasmid vectors that were used for co-expression.
1 was co-expressed with 2a and 2b separately.
Vector type
1. pColDuetGoxA

Constituting genes
GoxA gene including the

His-tag
C-terminal

leader sequence
2a. pETGoxB11

GoxB gene

C terminal

2b. pETGoxB11

GoxB gene

No His tag
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Results and discussion
The C-terminal goxA gene engineered into the pColADuet vector was coexpressed with the C-terminal goxB gene containing pET11 vector and also with the
untagged goxB in the pET11 vector. In both cases GoxA protein was expressed. But
unlike the pET15 vector containing both goxA and goxB gene on the same operon, the
overall yield of the protein was very low. The fact that the genes were not present on the
same operon probably lead to an inefficient complex formation between the GoxA and
the GoxB. Due to this essentially GoxA was generated with no or trace amounts of GoxB.
Figure 22 shows an SDS gel picture with the corresponding combinations. Samples from
the preps that used pET15 vector containing N-terminal His tagged GoxA was also run
on the gel for comparison. Upon carrying out the activity assay for these fractions it was
observed that they exhibited baseline levels of activity. This probably was due the weak
or no heterodimer formation between the 2 proteins as seen in the last chapter. This also
indicates the importance of the physical formation of the complex to facilitate the mature
CTQ formation in GoxA. The yield too did not improve upon changing the tags from the
N-terminal to the C-terminal. This indicated that the expression of matured CTQ
containing GoxA was absolutely dependent on its formation of complex with GoxB. Hence
having the 2 genes on 2 different operons did not optimize the expression condition. Once
the CTQ has been generated the GoxB comes off and is replaced by a monomer of GoxA.
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Lane:

1

2

3

4

5

Figure 22 SDS gel picture of the different GoxA expressions.
Lane 1 – protein molecular weight markers, lane 2 – fraction containing precursor GoxA
and GoxB complex expressed from the pET15 vector containing goxA and goxB gene on
the same operon, lane 3 – fraction containing matured GoxA from the same prep.
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CHAPTER 8: ROLES OF CONSERVED RESIDUES OF GOXAIN CONTROLLING
GLYCINE OXIDASE ACTIVITY, COOPERATIVITY, SUBUNIT COMPOSITION AND
CYSTEINE TRYPTOPHYLQUINONE BIOSYNTHESIS
Introduction
The glycine oxidase (GoxA)14 is the second enzyme to be isolated from the
melanogenic marine bacterium, Marinomonas mediterranea which bears the proteinderived cysteine tryptophylquinone (CTQ) cofactor6, 150. The first such enzyme was the
lysine-ε-oxidase (LodA)8. The biosynthesis of the CTQ cofactor of each enzyme requires
posttranslational modifications that are catalyzed by a specific flavoenzyme, GoxB or
LodB, respectively124, 151. In each case, the gene clusters contain only two genes, goxA
and goxB, and lodA and lodB. In addition to the interesting features of the biosynthesis of
CTQ in these enzymes, they exhibit atypical activities. All other known tryptophylquinone
enzymes that contain either CTQ or tryptophan tryptophylquinone (TTQ) are
dehydrogenases6,

150,

whereas GoxA and LodA are oxidases. The current study

characterizes the steady-state kinetic properties of GoxA and variants generated by sitedirected mutagenesis. Despite the similarities of GoxA and LodA, the results reveal that
the kinetic mechanisms of the two enzymes and roles of conserved active-site residues
are quite different.
LodA catalyzes the oxidative deamination of side-chain of L-lysine to generate a
semialdehyde, ammonia and H2O2 as products 8. The enzyme is secreted, and as a
consequence of the H2O2 generation exhibits antimicrobial properties that lead to
dispersal and differentiation of the biofilm in which the host bacterium resides
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10.

Steady-

state kinetic analysis using its substrates, lysine and O2, showed that LodA follows a pingpong kinetic mechanism involving a Schiff base intermediate formed between the ε-amino
group and CTQ152. This was verified by crystal structure of LodA with the lysine-CTQ
adduct formed132. Roles of residues in and around the active-site of the LodA in catalysis
and CTQ biogenesis were identified by site directed mutagenesis13.
GoxA catalyzes the oxidative deamination of glycine to generate a glyoxylate,
ammonia and H2O2 as products

14.

Whereas LodA exhibited typical Michaelis-Menten

behavior, the current steady-state kinetic study of GoxA reveals that it exhibits allosteric
cooperativity towards the glycine substrate. It was previously shown that purified active
GoxA eluted primarily as a dimer during size-exclusion chromatography 153. As the crystal
structure of GoxA has yet to be determined, a homology model is constructed from the
GoxA sequence and the LodA structure. Given the observed cooperativity and dimeric
structure, a docking model is also constructed in which the GoxA monomer is docked with
itself to form a putative dimer. The docking model predicts that the entrances to the activesite of each of the two monomers are in the proximity of the protein-protein interface.
Phylogenetic analysis of the Integrated Microbial Genomes database of genome
sequences
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revealed that LodA-like proteins can be clustered in five different groups

that were detected in several classes of bacteria and fungi. LodA is among proteins
classified as Group I LodA-like proteins and GoxA is present in Group II. Comparison of
the sequences of the Group I and Group II proteins with the structure of LodA and the
homology model of GoxA revealed candidates to target for site-directed mutagenesis
(Figure 1). Of particular interest was Phe237. Whereas all Group II proteins have a Phe
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in this position of the sequences, most Group I proteins including LodA have a Tyr in this
position. It is demonstrated herein that mutation of Phe237 to Tyr or Ala eliminates the
cooperativity exhibited by GoxA, and weakens dimer formation. His466 was of interest
because all Group II proteins each have His in this position, which is in proximity of CTQ
in the active-site, while the Group I proteins all have a Cys at the corresponding position.
Asp547 which also resides near CTQ was also of interest as this residue is conserved in
all Group I and Group II proteins as well as all other structurally characterized TTQdependent and CTQ-dependent enzymes 154-156. These results presented herein provide
insight into the roles of specific active-site residues in catalysis and CTQ biogenesis, as
well as describing an interesting mechanism by which a single residue can dictate
whether or not an enzyme exhibits cooperative allosteric behavior towards a substrate.
Materials and Methods
Construction, expression and purification of GoxA and its variants
Wild-type (WT) GoxA and GoxA variants that were generated by site-directed
mutagenesis were expressed by co-expression of the goxA gene with goxB in E. coli
Rosetta cells as described previously

153.

The GoxA proteins possessed a 6XHis tag

which was engineered into the gene. Preparation of cells extracts and purification using
a Ni-NTA affinity column was performed as previously described

153.

The following

mutations were made: D547A, H466A, H466D, H466C, F237A and F237Y. The forward
and reverse primers that were used are listed in Table 7. Using these primers the
mutations were incorporated by PCR using the QuikChange Lightning kit (Agilent).
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Table 7 Primers used for site-directed mutagenesis
Mutations
H466A

Primers
Forward - 5´GCATTCGCCCCTGGCGTCG 3´
Reverse - 5´CGACGCCAGGGGCGAATGC 3´

H466D

Forward - 5´ GGCGCATTCGATCCTGGCGT 3´
Reverse - 5´ ACGCCAGGATCGAATGCGCC 3´

H466C

Forward - 5´ GGCGCATTCTGTCCTGGCGTC 3´
Reverse - 5´GACGCCAGGACAGAATGCGCC 3´

F237A

Forward - 5´ GCTATTACGAGTGCCGCCGATAACGAT 3´
Reverse - 5´ ATCGTTATCGGCGGCACTCGTAATAGC 3´

F237Y

Forward - 5´ GCTATTACGAGTTACGCCGATAACGAT 3´
Reverse – 5´ ATCGTTATCGGCGTAACTCGTAATAGC 3´

D547A

Forward - 5´ TGGCAGTGTGCGGCCTTCAG 3´
Reverse - 5´ CTGAAGGCCGCACACTGCCA 3´
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Steady-state kinetic analysis
GoxA was assayed using a coupled enzyme assay in which the formation of the
NH3 product (eq 1) is monitored by coupling its production to the reaction of glutamate
dehydrogenase (eq 2). The standard assay mixture contained GoxA, 5 mM 2oxoglutarate, 0.25 mM NADH, and 20 U/ml glutamate dehydrogenase at 30˚C. The
reaction was initiated by the addition of glycine. The initial velocity was determined by
monitoring the rate of disappearance of NADH at 340 nm using the ε 340 of NADH of 6220
M-1cm-1. Initial rates were determined in the presence of varying amounts of glycine and
O2. To vary [O2], a stock solution of the buffer was made anaerobic by repeated cycles of
vacuum and purging with argon and then mixed anaerobically with an appropriate amount
of either air saturated buffer ([O2]= 252 µM) or 100% O2-saturated buffer ([O2]= 1150 µM)
buffer 145.
Glycine + O2+ H2O → glyoxylate + NH3+ H2O2

(7.1)

NH3 + 2-oxoglutarate + NADH  L-glutamate + H2O + NAD+

(7.2)

Two alternative equations were used to fit the data from the kinetic experiments.
In the Michaelis-Menten equation (eq 3) kcat is turnover number for the protein, Km is the
Michaelis-Menten constant, [S] is the substrate concentration, [E] is the enzyme
concentration and v is the initial reaction rate. In the Hill equation (eq 4) K 0.5 is the
concentration of the substrate that produces half the maximal velocity, and h is the Hill
coefficient.
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v/[E] = kcat[S]/(Km+[S])

(7.3)

v/[E]= kcat[S]h/ (K0.5)h + [S]h)

(7.4)

Size exclusion chromatography
Size exclusion chromatography was performed with an AKTA Prime FPLC system
using a HiLoad 16/600 Superdex 200 (GE Healthcare). Chromatography was performed
in 50 mM potassium phosphate buffer plus 150 mM NaCl at pH 7.5. The flow rate was
0.6 mL/min. The void volume was calculated using blue dextran. Proteins used as
molecular weight markers were a mixture containing glutamate dehydrogenase (332
kDa), methylamine dehydrogenase (124 kDa), MauG (42 kDa) and amicyanin (15 kDa).
A plot of the elution volume/void volume versus log molecular weight was used to estimate
the masses of the WT and variant GoxA proteins. Gaussian fits of the chromatogram
(using Origin and graphed in Prism Graph Pad) were used to resolve overlapping peaks
in the chromatogram and integrate the areas under the peaks.
Construction of homology and docking models
A homology model of GoxA was constructed with the sequence of goxA gene
(Marme_2396) and the structure of LodA (PDB 2YMW) using the SWISS-MODEL tool at
www.swissmodel.expasy.org

157.

A docking model of the putative GoxA dimer was

constructed by using the ZDOCK utility at http://zdock.umassmed.edu
generated from the homology model was docked against itself.
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158.

A PDB file

Results
Steady-state kinetic analysis of WT GoxA
Initially the concentration of the glycine was varied in the presence of 100% O 2saturated (1150 µM) buffer. Initial rates were measured and the data were fit to the
Michaelis-Menten equation (eq 3) (Figure 23A). While the fit was reasonably good
R2=0.97, the error ranges were high (kcat = 56 ± 5 s-1 and Km = 999 ± 172 µM) and a
systematic deviation to the fit was evident (i.e., data points clustered above and below
the fitted curve). The data were then fit to the Hill equation (eq 4) (Figure 23B) and a much
improved fit was obtained (R2=0.99). All data points now fall on the fitted curve. The
analysis yield values of kcat = 39±2 s-1 and K0.5 = 514 ± 42 µM. The fit also yielded a Hill
coefficient of 1.7 ± 0.2, indicative of positive cooperativity. Given the previous finding that
GoxA is a homodimer

153,

the h value of 1.7 is consistent with a kinetic mechanism in

which the binding of the first glycine molecule to one subunit enhances the affinity of the
second subunit for glycine. Next the concentration of O2 was varied in the presence of a
saturating concentration of glycine (5 mM). In this case the data were fit well by the
Michaelis-Menten equation (Figure 23C) and no improvement of the fit was obtained by
using the Hill equation (Figure 23D). Thus, GoxA does not exhibit cooperative behavior
towards O2, but only towards glycine. The analysis of the data using eq 3 yielded values
of kcat = 93 ± 18 s-1 and Km = 2590 ± 690 µM.
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Figure 23 Steady-state kinetic analysis of GoxA.
Assays of glycine oxidase activity were performed with varied concentrations of glycine
in the presence of a fixed concentration of 1150 µM O2 (A and B) or with varied
concentrations of O2 in the presence of a fixed concentration of 5 mM glycine (C and D).
The lines are fits of each data set by either eq 3 (A and C) or eq 4 (B and D).
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A couple of points are noteworthy. These results indicate that the Km for O2 is
actually greater than the [O2] in a 100% O2 saturated solution, and much greater than in
air-saturated buffer. For this reason the assays were repeated anaerobically in the
presence of alternative small molecule electron acceptors to see whether GoxA could
function as a dehydrogenase. However, no activity was observed when replacing O2 with
NAD+, ferricyanide, phenazine ethosulfate or dichlorophenolindophenol. Also, the kcat
obtained when varying O2 was 93 s-1 compared to 39 s-1 when varying glycine. The reason
for this is that the fixed concentration of O2 that was used, which is the highest that can
be achieved, was not a saturating concentration (i.e. was not much greater than the Km
for O2). Thus, the lower value is an apparent kcat determined at sub-saturating
concentration of the fixed substrate, and the value of 93 s-1 determined by varying O2 at
a true saturating concentration of glycine is a more valid estimation of the true kcat.
Because of the cooperative behavior towards glycine and the inability to achieve
saturating concentrations of O2, it was not possible to perform the experiments in which
both substrates could be varied over the appropriate range of concentrations necessary
to determine whether or not GoxA obeys a ping-pong mechanism, as was done with LodA
152.

Structural comparisons of GoxA with LodA
The crystal structure of GoxA has not yet been determined but it was possible to
construct a homology model of the structure based on its sequence and the crystal
structure of LodA (Figure 24A). Alignment of the homology model of the structure of GoxA
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with LodA reveals strong structural conservation of the active sites (Figure 24B). It shows
that the CTQ cofactor in GoxA is formed from Cys551 and Trp566. These residues were
previously shown by proteolysis and mass spectrometry of GoxA to form CTQ

11,

thus

supporting the validity of the model. For reasons discussed earlier, Asp547, His466 and
Phe237 of GoxA were chosen as candidates for site-directed mutagenesis to elucidate
structure-function relationships.

Phe237 is of interest because it corresponds in

sequence to Tyr211 of LodA, which is conserved in most Group I proteins and which
strongly influenced the Km values of both lysine and O2 for LodA 13. In the homology model
the position of Phe237/Tyr211 is not structurally conserved as are the positions of CTQ
and the other two residues. Furthermore, in LodA Lys530 forms a hydrogen bond with
Tyr211, but no Lys is present in this position in GoxA.
Effects of site-directed mutagenesis on active-site residues of GoxA
Asp547. Mutation of Asp512 in LodA affected CTQ biosynthesis and so its effect on the
activity of the mature enzyme could not be assayed

11.

The analogous D547A mutation

was made in GoxA. This resulted in protein with no activity. Furthermore, the inactive
protein was isolated primarily in complex with the modifying enzyme GoxB. It was
previously shown that a precursor of WT GoxA which lacks CTQ forms a tight complex
with GoxB

153.

Thus, Asp547 in GoxA must also be play a role in CTQ biosynthesis on

GoxA.
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Figure 24 Overlays of the homology model of GoxA with the crystal structure of
LodA (PDB ID 2YMW).
(A) The overall structures of monomers of LodA (green) and GoxA (orange) are
superimposed. (B) The active sites of GoxA and LodA are superimposed. The Cys and
Trp residues which form CTQ and selected other residues are shown as stick. Carbons
on residues of LodA and GoxA are colored green and orange, respectively. Oxygen is
colored red, nitrogen blue and sulfur yellow.
110

His466. His466 corresponds to the Cys448 of LodA. That residue was mutated to Ala,
Asp and His 13. No stable C448H LodA protein was isolated, suggesting that the mutation
affected the biosynthesis or stability of the protein, or both. C448A LodA and C448D LodA
could be isolated. Those mutations had little effect on kcat but each increased the Km
values for both lysine and O2 13. The corresponding H466C, H466A and H466D mutations
were made in GoxA. As described above for D547A GoxA, each of these three variant
proteins could only be isolated in a complex with GoxB and exhibited no activity. Thus, it
appears that His466 is also important for GoxB-dependent CTQ biosynthesis in GoxA.
As such, the roles His466 and Asp547 in catalysis by GoxA could not be studied, as the
mutations compromised CTQ biosynthesis.
Phe237. Phe237 corresponds to the Tyr211 of LodA. That residue was mutated to Phe
and Ala. Y211A LodA was inactive and Y211F LodA exhibited a decreased kcat and
significantly increased Km for both lysine and O2 13. Phe237 in GoxA was converted to Tyr
and Ala. The F237Y GoxA variant protein was isolated and assayed. As with WT GoxA,
activity was measured at varied concentrations of the glycine in the presence of O 2saturated (1150 µM) buffer. In contrast to what was observed for WT GoxA, the data for
F237Y GoxA did fit well to the Michaelis-Menten model (Figure 25A). No improvement of
the fit was obtained using the eq 4 and the fit to that equation yielded a Hill coefficient
value of approximately 1. This indicates that the cooperativity towards glycine exhibited
by WT GoxA is lost as a consequence of the F237Y mutation.
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Figure 25 Steady-state kinetic analysis of GoxA variants.
Assays of glycine oxidase activity of F237Y GoxA were performed with varied
concentrations of glycine in the presence of a fixed concentration of 1150 mM O2 (A) or
with varied concentrations of O2 in the presence of a fixed concentration of 5 mM glycine
(B). Assays of glycine oxidase activity of F237A GoxA were performed with varied
concentrations of glycine in the presence of a fixed concentration of 1150 mM O2 (C) or
with varied concentrations of O2 in the presence of a fixed concentration of 5 mM glycine
(D). The lines are fits of each data set by either eq 3.
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Table 8 Steady-state kinetic parameters for GoxA and GoxA variant proteins

WT GoxA
kcat (s-1)b

93 ± 18

K0.5 glycine (µM)

514 ± 42c

Km glycine (µM)

-

Km lysine (µM)
Km O2 (µM)
kcat/KmO2 (M-1s-1)

F237AGoxA

LodAa

15 ± 5

0.6 ± 0.1

0.22 ± 0.04

-

-

-

F237Y GoxA

3030 ± 840

826 ± 123

-

-

-

3.2 ± 0.5

2600 ± 693

2270 ± 1000

416 ± 157

37.2 ± 6.1

36000

6600

1000

5900

aTaken

from reference 12.
values are from the experiments in which O2 was varied rather than from studies
where glycine was varied since it was not possible to achieve saturating concentration
of O2
cWT GoxA fit best to eq 4 and so the K
0.5 value is used rather than a Km value.
bkcat
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Activity was also assayed by varying the concentration of O 2 in the presence of a
saturating concentration of glycine (Figure 25B).Comparison of the fitted values of the
kinetic parameters (Table 8) indicates that the F237Y mutation decreased kcat and
increased Km for glycine with little effect on the Km for O2. The F237A GoxA variant protein
was also isolated and analyzed (Figure 25C and D). This variant also obeyed MichaelisMenten kinetics without cooperativity towards glycine. The fitted values of the kinetic
parameters (Table 8) indicate that this mutation substantially reduced kcat, had little effect
on the Km for glycine, and substantially decreased the Km for O2. Thus, Phe237 not only
dictates cooperative behavior towards glycine but also influences the kcat and Km values
for both glycine and O2.
Effects of Phe237 mutations on the oligomerization state of GoxA
In order to determine whether mutations of Phe237 which abolished cooperativity
also affected the stabilization of the native homo-dimeric state of GoxA, the WT and
variant proteins were analyzed by size exclusion chromatography. WT GoxA (Figure 26A)
elutes from the column primarily as a dimer. One observes a minor peak at about 76 kDa
(16%) which corresponds to the predicted mass of a monomer and a major peak at
approximately 140 kDa (84%). In contrast, the majority of F237Y GoxA (Figure 26B)
elutes as a monomer with a major peak at 76 kDa (62%) and a minor peak at 140 kDa
(38%). The majority of F237A GoxA (Figure 26C) also elutes as a monomer with a major
peak at 76 kDa (68%) and a minor peak at 140 kDa (32%).
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Figure 26 Size exclusion chromatography
WT GoxA (A), F237Y GoxA (B) and F237A GoxA (C). The positions of elution of molecular
weight marker proteins are indicated.
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A docking model of the GoxA dimer
In order to gain insight into how Phe237 might be involved in the cooperativity and
stabilization of dimer formation, a protein docking model was constructed using the
ZDOCK program (Figure 27). Interestingly, it shows the Phe237 resides at the proteinprotein interface and that the Phe237 residues of each subunit are in close proximity to
each other when present as a dimer. Phe237 is also in a position in which it may interact
with other aromatic amino acids residues that are present at the interface, Tyr618 and
Trp619. In fact, the Tyr618 residues of the two monomers are at a distance of 1.7 Å from
each other. The inter-subunit distance between the Trp691 residues of each monomer is
about 4 Å. The aromatic residues being in such close proximity suggests the possibility
of π-stacking between the side-chains. Since the model used to estimate the distances
between these residues is a homology model, the values thus obtained are approximate.
However, π-stacking interactions between residues would likely induce the other amino
acids to rearrange themselves. Thus, these residues may be important in the stabilization
of the dimeric structure and the communication between the two active sites that results
in the observed cooperativity of WT GoxA.
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Figure 27 Docking model of the GoxA monomers to form a dimer structure.
The two monomers are colored blue and pink respectively. (A) The overal structure of the
dimer with residue Phe237 shown in stick. (B) An expanded view of the protein-protein
interface of the two monomers. The Cys and Trp residues which form CTQ and selected
residues at the interface are shown as stick. Carbons on residues of LodA and GoxA are
colored blue and pnik, respectively. Oxygen is colored red, nitrogen blue and sulfur yellow
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Discussion
GoxA and LodA are CTQ-containing oxidases discovered in the same bacteria, M.
mediterranea. Each of them belongs to a new class of unusual tryptophylquinone
cofactor-containing oxidases. Analysis of the Integrated Microbial Genomes database of
genome sequences identified 168 genes from 144 different species that encode LodAlike proteins

125.

Prior to the characterization of LodA and Gox, all known quinoprotein

oxidases contained a tyrosylquinone cofactor

159,

and in general all amino acid oxidases

contained a flavin cofactor160. Despite the similarities in sequence and structure exhibited
by GoxA and LodA, there are interesting differences in their kinetic mechanisms and
steady-state kinetic parameters. This could be a consequence of different physiological
roles of the proteins. LodA is a secreted protein which exhibits antimicrobial activity that
is important for the health of the biofilm in which the host bacterium resides 10. GoxA has
also been reported to exhibit antimicrobial activity, however the finding of cooperativity
towards glycine and production of glyoxylate, which is an important metabolite 161,
suggests a possible metabolic and regulatory functions.
GoxA exhibits cooperative behavior towards its glycine substrate whereas LodA
exhibits no cooperativity. The Km values for glycine and O2 for GoxA are each much
greater than for LodA, however the kcat value of GoxA is also much greater than that for
LodA. Thus, despite the very large Km value which GoxA exhibits for O2, the catalytic
efficiency kcat/KmO2 for GoxA is actually six-fold greater than that of LodA (Table 2). Thus,
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LodA seems to have evolved its catalytic efficiency by increasing affinity for substrates,
which GoxA has improved its catalytic efficiency by increasing kcat.
Asp547 and His466 of GoxA appear to be critical for CTQ biosynthesis. The
corresponding Asp512 in LodA was also shown to be critical for CTQ biosynthesis, while
certain substitutions of Cys448 of LodA, which corresponds to His466, were tolerated

13.

The tolerated mutations did, however, significantly increase the Km value for lysine and
altered the efficiency of CTQ biosynthesis. These results for the CTQ-dependent
enzymes are reminiscent of those from studies of TTQ biosynthesis in MADH

162.

The

active site of that enzyme has Asp in each of these two corresponding positions, Asp76
and Asp32. Mutation of the Asp76 that corresponds in position to Asp547 in GoxA
resulted in production of only trace amounts of protein which lacked TTQ. Mutation of the
Asp32 which corresponds in position to His466 in GoxA resulted in isolation of a mixed
population in which some protein was active, albeit with significantly decreased affinity
for substrate, and some lacked TTQ

162.

This highlights the fact that these active site

residues which likely play roles in catalysis or substrate binding, or both, must have
previously evolved to facilitate the process of CTQ biosynthesis.
The protein interface of the GoxA dimer predicted from the modeling studies
is completely different from what was observed in the crystal structure of LodA

132.

LodA

crystallized as a tetramer. Each LodA monomer has an unusual structure with two arms
of antiparallel β-strands extended from the main body of the subunit. These extensions
participate in subunit interactions. The primary sequence of this structural feature of LodA
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is not present in GoxA, consistent with it exhibiting a different subunit composition and
different subunit-subunit interactions.
The importance of Phe237 of GoxA in stabilizing subunit-subunit interactions and
dictating cooperative behavior towards glycine is remarkable. The F237Y and F237A
mutations each eliminated cooperativity towards glycine. However, the F237Y mutation
decreases kcat about six-fold and decreases KmO2 slightly, while the F237A mutation
decreases kcat 155-fold and decreases KmO2, six-fold (Table 4.4.2). Despite the
differences in the effects on the kinetic parameters of substitution with Ala versus Tyr, the
destabilization of the dimer by the F327A mutation is only slightly greater than for the
F237Y mutation (Figure 4). This indicates that activity is not strictly dependent upon dimer
formation. This also means that F327 of GoxA exerts a significant influence on the kcat
and affinity for substrates as does Tyr211, the corresponding residue in LodA. In LodA
the Y211A mutation eliminated activity while the Y211F mutation caused a small
decrease in kcat but a large increase in Km for lysine 13.
At this point one can only speculate on the mechanism by which Phe237 stabilizes
dimer formation and is involved in the communication between subunit active sites that
results in cooperativity. As discussed earlier, the docking model suggests the possibility
that strong π-interactions and π-stacking involving Phe237 and surrounding aromatic
residues could be involved in these processes. A different structural role for Phe237 in
GoxA than for Tyr211 in LodA is also consistent with the absence of a residue that
corresponds to Lys530 in LodA. The crystal structure of LodA suggested that Tyr211,
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which resides on a flexible loop near the entry to the substrate channel, formed a
hydrogen bond with Lys530 creating a gate-like structure to control entry and exit of
substrate and the products from the active site. Because of the absence of hydrogen bond
to the corresponding Phe237, the corresponding loop in GoxA and consequently Phe237
adopts a different position (Figure 5) which now involves protein-protein interactions.
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CHAPTER 9: CONCLUSION
This study involves the structural and functional characterization of two
oxidases, LodA and GoxA originally found in the same bacterium, Marinomonas
mediterranea. They are unique as they are the first reported examples of
tryptophylquinone cofactor containing oxidases. Both of them contain CTQ and carry out
oxidative deamination of amino acids, L-lysine and glycine respectively. Steady state
kinetic analysis of LodA and GoxA showed difference in their mode of reaction catalysis.
GoxA displayed allosteric cooperativity for glycine whereas LodA did not for its substrate,
L-lysine. The cooperativity of GoxA was supported by the presence of the enzyme as a
dimer. Regulation of substrate interaction was also different in the two proteins. In LodA
it occurred by the gate-like formation generated by the H-bonded Lys530 and Y211. In
GoxA it occurred by the dimer formation mediated by Phe237. Thus the kinetic and sitedirected mutagenesis studies have revealed the possibility of two different physiological
functions of LodA and GoxA in the microorganism, one being antimicrobial and the other
being metabolic, respectively.
Various key points have been identified in this study. Site-directed
mutagenesis has shown the importance of a single amino acid residue in stabilizing the
structure and conformation of an enzyme. It has also highlighted another very significant
aspect regarding the evolution of these enzymes. It is evident that they have been
optimized for their functions but not essentially for selectivity, activity and cofactor
generations as some mutants did show better CTQ formation than the wildtype, but ended
up having compromised or no activity. The kinetic studies have also shown how enzymes
122

with similar cofactors but different physiological functions could maximize their catalytic
efficiencies by merely adjusting kinetic parameters like kcat and Km. Most importantly since
this has been the first detailed structural and functional analysis of CTQ containing
oxidases, it will help in broadening the horizon of understanding posttranslational
modifications of amino acids in quinoproteins.
In future this study could help in characterizing similar CTQ containing proteins
which have been discovered recently as constituting a whole new pool of
tryptophylquinone cofactor containing oxidases. The biosynthesis of CTQ cofactor has
not yet been well characterized. The mutagenesis studies have already implicated the
importance of certain amino acid residues in the CTQ biosynthesis process. Furthermore,
the isolation of the complex of the two proteins one of which catalyzes the cofactor
formation and the other being in a precursor form will help in determining the mechanism
of cofactor biogenesis. Another interesting aspect would be to study the flavoproteins,
LodB and GoxB. No flavoprotein has yet been reported to catalyze a quinone cofactor
formation. Characterizing these will help in identifying the similarities and differences with
the already reported flavoproteins that function as oxidases and catalyze redox reactions.
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